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Thesis Summary 
Background: 
Africa carries the dual burden of malnutrition co-existing with HIV infection. Under-
nutrition underlies almost half of the under-five childhood deaths while HIV/AIDS is 
among the top 10 causes of childhood mortality. Though under-nutrition is an 
essential problem in under-five children, it has also remained an important issue in 
school-aged children from low income settings and has many adverse 
consequences that can be immediate or long term. Under-nutrition is often 
associated with macronutrient and micronutrient deficiencies. Iron deficiency, a 
multisystem disorder leading to anaemia, is the commonest micronutrient deficiency 
globally. Less commonly described micronutrients such as selenium deficiency 
burden have not been clearly defined in children from low income setting particularly 
ones with high HIV infection burden. In addition, there is very limited information 
concerning important macronutrient deficiencies such as omega 3 fatty acids which 
coupled with the multiple micronutrient deficiencies associated with under-nutrition 
plus HIV infection contribute to poor growth and neurodevelopmental outcomes of 
children. 
The objectives of this thesis were to measure the prevalence of malnutrition, 
anaemia, iron deficiency, selenium deficiency and describe the omega 3 fatty acid 
status in HIV unexposed and HIV exposed (infected and uninfected) children 7 to 10 
years old who were born in a national mother-to-child transmission of HIV infection 
prevention programme (The BHAMC study) from a peri-urban setting in Zimbabwe, a 
low income country with a high burden of HIV infection. 
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Methodology: This cross-sectional study was a sub-study in the BHAMC study 
which recruited mother-baby pairs between 2002 and 2004 and was designed to 
assess impact of sexually transmitted infections on mother-to-child transmission of 
HIV infection. The study was carried out at 3 peri-urban primary care clinics, just 
outside Harare the capital city of Zimbabwe, offering maternal and child health 
services from August 2011 to June 2012.  
Main outcome measures- The main outcome measures were the nutritional 
status(stunting, thinness, underweight, overweight), haemoglobin, serum Ferritin, 
soluble transferrin receptor, serum selenium and omega 3 fatty acid levels 
[Eicosapentaenoic acid (EPA), Docosapentaenoic acid (DPA) and docosahexaenoic 
acid(DHA)]. The nutritional status was defined using the World Health Organization 
(WHO) criteria for classifying nutritional status of children between 5 and 18 years. 
Results: A total of 318 participants 7 to 10 years old were recruited of whom 21 
(7%) were HIV infected, 116 (36%) HIV negative exposed and 180(57%) HIV 
negative unexposed. Majority of the children were in the 8 and 9 year old age 
groups. There were more female participants (57%). Prevalence of stunting, 
thinness, underweight and overweight was 12%, 4%, 8% and 5% respectively. 
Stunting was associated with HIV infection and exposure.  Selenium deficiency 
(<0.89μmol/L) was present in 129 (48%) children. Selenium deficiency was 
associated with monthly household income below US$250 and was not related to the 
participant’s HIV status. The prevalence of anaemia (Hb<11.5g/dL), iron deficiency 
(Ferritin<15μg/L) and iron deficiency anaemia (Hb<11.5g/dL and either F<15μg/L or 
sTfR>8.3μg/L) were 15%, 4% and 2% respectively. When a higher cut-off for ferritin 
(<30μg/L) was applied, prevalence of ID and IDA increased to 32% and 5% 
respectively. Anaemia was more likely to be present in HIV infected children (p-
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value<0.001) with an odds ratio of 4.9 (CI 1.9- 12.4). The 7 year old age group had 
the lowest EPA levels. There was no difference in EPA, DPA and DHA levels by HIV 
status, gender and nutritional status. 
Conclusions and recommendations: 
Chronic under-nutrition and selenium deficiency were common in these 7-10 year old 
children, therefore nutrition programmes targeted for children above 5 years are 
recommended in our setting and they should be continuous with the already present 
nutrition programmes for under-fives. More research is required to ascertain 
selenium status of all children from our setting including rural and urban children 
above and below 5 years as this may guide the need for supplementation of this 
micronutrient in our setting. 
Prevalence of anaemia and ID were of mild public health significance. Anaemia 
association with HIV infection calls for strengthening of mother-to-child transmission 
of HIV prevention programmes in our setting as preventing HIV infection in children 
could help reduce anaemia burden in children above 5 years. ID can be addressed 
by teaching consumption of iron rich foods and fortification of basic foods. 
This study did not find any differences in omega 3 fatty acid status by HIV status, 
gender and nutritional status from a peri-urban setting with high burden of HIV and 
under-nutrition. Further and larger studies are recommended that include urban and 
rural children to ascertain the relationship of omega 3 fatty acid levels with HIV 
status plus nutritional status.  
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1. INTRODUCTION AND BACKGROUND  
1.1 Introduction 
1.1.1 Global Prevalence of Malnutrition in Children 
Malnutrition encompasses both under-nutrition and over-nutrition [1]. Under-nutrition 
describes growth failure often associated with macronutrient and micronutrient 
deficiencies as a result of poor nutrition. Over-nutrition represents excess nutrient 
and energy intake that results in adverse health outcomes. The global prevalence of 
stunting, underweight and wasting in under-five children has been declining since 
1990 [2] contrasting with the prevalence of overweight which has increased during 
the same period. Almost a quarter of the under-five children in the world are stunted 
[2]. Under-nutrition leads to delayed motor development, cognitive impairment, 
behavioural problems, social development deficiency, immunodeficiency, increased 
morbidity and mortality [3, 4]. 
Africa and Asia carry more than 90% of the burden of under-nutrition in under-fives 
globally [2]. For Africa this means that the high burden of under-nutrition is co-
existing with a high prevalence of HIV/AIDS [5] since the majority of HIV infected 
people are found on this continent. HIV infection and under-nutrition are two 
important factors that contribute to a significant proportion of under-five mortality. 
Under-nutrition underlies almost half of the under-five childhood deaths [6] while 
HIV/AIDS is in the top 10 causes of under-five deaths globally and contributes about 
three percent to childhood deaths in sub-Saharan Africa [7]. In Africa, the prevalence 
of HIV infection is highest in the sub-Saharan region [5].  
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1.1.2 Malnutrition in Zimbabwe 
Zimbabwe is a land locked country situated in sub-Saharan Africa (See to Figure 1). 
It has a population of approximately 13 million people [8]. The country has 
experienced economic problems since the last two decades which peaked in 2008 
with the country experiencing phenomenal inflation rates. A multi-currency system 
was introduced in 2009 and helped stabilize the economy [9]. Zimbabwe has a low 
human development index and was ranked 156 out of 187 countries in the 2014 
United Nations Development Programme (UNDP) report [10]. Currently, the national 
prevalence of poverty is 63% with 16% of the population experiencing extreme 
poverty. People living in the rural areas experience more poverty (76%) compared to 
urban dwellers (38%) [9]. Approximately a fifth of households in rural areas 
experience moderate to severe hunger. In April 2014, 35% of children 6 to 59 
months were reported to have less than 3 meals a day [9]. A quarter of the 
households in Zimbabwe also look after orphaned children. 
 
Under-nutrition is a key problem in Zimbabwe and is aggravated by the economic 
decline experienced since 1990 and the HIV/AIDS epidemic [11]. The Zimbabwe 
Demographic Health Survey (ZDHS) 2010/2011 showed that for under five children, 
 
Figure 1 World Atlas 
Map showing location 
of Zimbabwe (Google 
Maps) 
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32% were stunted, 3% were wasted, 10% were underweight and 15% were 
overweight [12] as shown in Figure 2. The prevalence of stunting and underweight 
has remained unacceptably high in the past two decades but prevalence of wasting 
has declined in the same period of time. Overweight trends have not changed much 
since 1999 but dropped to 11% during the time of economic meltdown in 2005 to 
2006. These prevalence figures are based on the 2006 World Health Organization 
(WHO) growth charts for children under 5 years [13]. Of note is that the ZDHS does 
not assess the nutritional status of children above 5 years. While the problem of 
under-nutrition has been prioritized and well defined for under-fives in low income 
countries with a high prevalence of HIV infection, school going children remain a low 
priority in nutrition programmes from these settings. 
 
Figure 2 Trends in Nutritional Status of Under 5 Children from Zimbabwe 
 
Source: ZDHS 2010/2011 
1.1.3 The HIV Epidemic in Zimbabwe 
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Zimbabwe is located in the heart of the HIV epidemic and it is the only country in 
Southern Africa that has recorded a substantial decline in the prevalence of HIV 
infection in adults (see Figure 3). The adult HIV prevalence has been declining in the 
last decade from 27% but still remains high at 15% for the year 2014 [14]. The new 
HIV infections in adults have decreased from above 230 000 annually (1997) to 
below 60 000 (2014) [15]. The number of new HIV infections have also declined from 
37 000 (1999) to 3 500 (2014) in children below 15 years of age. Prevalence of HIV 
infection in children below 15 years is currently 2.7% (see Table1).  
Figure 3 Trends in the adult prevalence of HIV infection in Zimbabwe 
 
Source: Zimbabwe Global AIDS Report 2015 
Life expectancy at birth has increased from 36.5 years in the year 2002 to 59.9 years 
in 2014 [10]. Under 5 mortality rate for the year 2014 was 75 deaths per 1000 live 
births [16] and this represents a decline from 102 deaths per 1000 live births 
recorded in 1999 during the peak of the HIV epidemic [12]. HIV/AIDS contributes  
21% to under-five mortality [12] in Zimbabwe. In response to the HIV epidemic the 
prevention of mother-to-child transmission of HIV (PMTCT) programme was initiated 
in 1999 using single dose nevirapine. The government of Zimbabwe declared a state 
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of emergency in 2002 [17] and the anti-retroviral therapy (ART) programme was 
initiated in 2004 [17]. The multiple ART for PMTCT was adopted by the country in 
2008 using the WHO option A (see Table 2). Option B+ was launched in November 
2014. It is estimated that in 2015 approximately 70 000 pregnant women and 113 
000 children will require PMTCT and ART services respectively [15].  
Table 1 Zimbabwean HIV/AIDS Statistics: 1999 and 2014  
 Characteristic Year   
 1999 2014 
Total Number People living with HIV 1,758,402 1,420,604 
Number of Children <15 years living with HIV 141,109 156,718 
Adult ≥15 years HIV Prevalence  25.72 % 14.80 % 
HIV Prevalence Children  3.05 % 2.66 % 
New HIV infections Adults ≥15 years 120,289 59,339 
New HIV infections Children <15 years 36,778 3,587 
Total Annual AIDS Deaths (Adults and Children) 117,768 42,534 
Annual AIDS Deaths Children < 15 years 22,332 6,176 
AIDS Orphans 1,057,494 841,939 
Life Expectancy 37.8 years 59.9 years 
Under Five Mortality  102 75 
Source: Zimbabwe National HIV and AIDS Estimates 2013; Global AIDS Response Progress Report 2015 and 
UNDP Report 2014 
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Table 2 Summary WHO recommendations for PMTCT and ART Treatment 
Guidelines  
Year 
Launched 
2001 2004 2006 2010 2013 
PMTCT 4 weeks AZT; 
AZT+ 3TC,  or 
sdNVP 
AZT from 
28 weeks 
+ sdNVP 
AZT from 
28weeks + 
sdNVP 
+AZT/3TC 
7days 
Option A  
(AZT 
+infant 
NVP) 
Option B  
(triple 
ARVs) 
Option B or 
B+ 
Moving to 
ART for all 
Pregnant and 
breastfeeding 
women 
Adult ART No 
recommendation 
CD4 
<200 
CD4 <200 CD4 <350 CD4 <500 
Paediatric 
ART 
No 
recommendation 
CD4 
guided 
treatment 
of 
advanced 
disease 
CD4 
guided 
treatment 
of 
advanced 
disease 
Treat all 
infants 
below 2 
years  
All children<5 
years 
sdNVP Single dose Nevirapine; AZT Zidovudine; 3TC Lamivudine; ARVs Antiretrovirals; 
ART Anti-retroviral Therapy 
Source: WHO http://www.who.int/hiv/pub/guidelines/en/ 
 
1.2 Background 
Malnutrition can be acute, chronic or both. The indices that combine weight with 
height [weight-for-height (wasting) and Body Mass Index (BMI) (thinness)] are used 
to define acute under-nutrition and over-nutrition (overweight/obesity) for different 
age groups while height for age describes chronic under-nutrition (stunting). Acute 
under-nutrition is important since it results in a limited ability to respond to stresses 
such as infection. Acute under-nutrition has been reported to increase risk of dying 
with moderate and severe acute under-nutrition having mortality rates of 30-115 and 
73-187/ 1000/year respectively according to data from Africa as well as Asia [4]. 
Consequences of stunting include cognitive impairment [18-22], short stature in 
adults [23-25], poor reproductive outcomes [26], reduced economic productivity [27], 
and later risk of obesity as well as chronic diseases [28]. Weight for age indicator is a 
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composite representation of both wasting and stunting [29]. Mid-upper-arm-
circumference (MUAC) indicates wasting while head circumference is a proxy for 
brain growth. MUAC identifies under-nourished children at high risk of dying [30]. 
MUAC performed as well as weight-for-height Z score in predicting inpatient mortality 
in 12 to 59 months old children with SAM in a rural malaria endemic coastal area in 
Kenya [31]. It also has the advantage that it is cheap and easier to perform 
compared to measuring height and weight as well as being easier to interpret. In 
rural South Africa, MUAC was noted to have potential use in identifying obesity in 
children 5 to 14 years old [32]. Therefore, besides MUAC use in identifying under-
nourished children below 5 years at high risk of dying, it also may have a role in 
screening for over-nourished older children.  
Management of acute malnutrition should be proactive and short duration highly 
intensive regimes are used for treatment. Currently, the WHO recommends a 
programme of using community based approach [33] for treatment of both acute 
moderate and severe malnutrition using ready-to-use-supplementary-food (RUSF) or 
ready-to-use-therapeutic-food (RUTF) respectively for children above 6 months (see 
Figure 4). This programme consist of inpatient stabilisation care for management of 
complicated severe acute malnutrition (SAM), outpatient therapeutic component for 
uncomplicated SAM and supplementary feeding for moderate acute malnutrition 
(MAM) [34].  The RUTF and RUSF are lipid rich pastes enriched with powdered 
ingredients producing a high energy food with low water content. The low water 
content in RUTF and RUSF discourages microbial contamination and growth; hence 
they can be stored at ambient temperature even in the tropics for a few months [35]. 
The constituents of RUTF and RUSF include milk powder, vegetable oil, sugar, 
peanut butter and powdered vitamins and minerals.  Zimbabwe adopted and is 
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implementing this integrated approach to management of acute malnutrition. Active 
identification of acutely malnourished children in the community is done using MUAC 
and screening for pedal oedema. However, effectiveness of the intervention on catch 
up growth of acutely malnourished children may depend on the specific context of 
implementation [36].  
Long term preventive programmes to improve nutrition, maternal and infant health 
are needed to address chronic malnutrition.  Adequate maternal nutrition in 
pregnancy including micronutrient supplementation; promotion of exclusive 
breastfeeding; provision of adequate complementary feeds; proper water, sanitation 
and hygiene to reduce infections; poverty alleviation programmes; health services 
improvement for both women and children as well as improving maternal education 
are some of the multi-sectorial evidence based interventions for reducing stunting in 
children [37, 38].  
1.2.1 Nutritional Status of Children Under-five and School Aged HIV Exposed 
and Unexposed Children from Low Income Countries 
High levels of stunting, wasting and underweight have been reported in the postnatal 
period in children from areas with increased burden of HIV infection. In India [39] and 
South Africa [40], researchers have reported early occurrence of under-nutrition 
before age three months in HIV infected infants [39]. However, in Tanzania, 
researchers reported later occurrence of under-nutrition in children born to HIV 
infected women with median time to first episode of stunting, wasting and 
underweight all occurring after six months of age [41]. Under-nutrition occurs more 
frequently in HIV infected infants as reported in South Africa [40] and in children 
below two years as reported in the Democratic Republic of Congo [42]. Under-
 
 
21 
 
nutrition has also been noted to be frequent in HIV exposed but uninfected infants in 
Kenya [43]. 
Figure 4 Conceptual framework Integrated Management of Acute Malnutrition 
 
SC Stabilisation care; OTP Outpatient therapeutic programme; SFP Supplementary feeding 
programme 
Source: Community Therapeutic Care Field Manual, 2006 
 
Multiple factors have been associated with occurrence of under-nutrition in the 
postnatal period which includes socio-demographic, immunological and 
environmental factors. The maternal factors include advanced HIV infection, young 
age and low maternal education. Poverty, not breastfeeding, early weaning and 
residing in the rural areas are some of the socio-environmental factors contributing to 
the under-nutrition. The child factors associated with under-nutrition included HIV 
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infection, anaemia, low birth weight, prematurity, male gender as well as repeated 
infections such as malaria and diarrhoea  [39-41, 44, 45]  in these settings with high 
burden of HIV infection. Regarding all children despite their HIV infection status, a 
window of opportunity has been described for interventions to prevent under-nutrition 
in the first 1000 days of life as it has been noted that under-nutrition particularly 
stunting begins in utero [37]. Once children become stunted in early life it is very 
difficult for catch up growth to occur as long as the child remains in the same 
environment [46]. The children that become stunted before 24 months of age tend to 
remain stunted into adult hood   and suffer the long term consequences of stunting 
which tend to  affect even the next generations [47, 48].  
Stunting and wasting remain problematic in school-aged children from Africa [49-52]. 
High prevalence of stunting has been documented in rural school children 8 to 11 
years old from South Africa [53]. There are reports on paradoxical co-existence of 
over-nutrition and under-nutrition in 5 to 14 year old children from Pakistan [54]. 
Malnutrition affects growth, development, mental and physical capacity in school-
aged children [55]. It is essential to offer interventions to correct and prevent under-
nutrition especially stunting in school aged children since it is associated with 
cognitive deficits [56-58]. Despite the fact that stunting is very difficult to reverse 
especially if children remain in the same environment [59], Tanzanian children 
demonstrated considerable catch-up growth in the pubertal period [60].  Catch up 
growth in Ethiopian, Indian, Vietnamese and Peruvian school aged children followed 
up between 8 and 15 years was associated with improved cognitive function [57, 61]. 
Factors associated with catch-up growth of children above 5 years include birth 
length, less severe stunting, gender, household wealth, modernization, maternal 
 
 
23 
 
education and maternal height [61-63].  It is important to identify and correct 
malnutrition in school-aged children. 
1.2.2 Nutrition and HIV 
HIV infection can result in malnutrition by reducing nutrient intake, increasing nutrient 
requirements of the body, altering metabolism and increasing nutrient losses from 
the body [64-68]. Nutrient intake is reduced through several mechanisms. HIV 
infection affects human capacity to work and therefore causes food insecurity at the 
household level [69]. The opportunistic infections (OIs) in HIV infected individuals 
can cause painful oral conditions that reduce intake of nutrients. Both HIV and OIs 
cause fever which is associated with reduced appetite [67]. HIV infection alters 
metabolism [65, 66] by increasing the resting energy expenditure [70, 71]. Increased 
susceptibility to OIs will also increase metabolic requirements and result in increased 
nutrient demand which worsen the nutritional status of individuals with HIV infection 
[67]. Furthermore, HIV infection effects on the gut include increased diarrhoea 
episodes and malabsorption [72-75] which result in nutrient losses from the gut. HIV 
and malnutrition both depress the cellular as well as humoral immunity [67] resulting 
in enhanced susceptibility to OIs therefore increasing morbidity and mortality. HIV 
infected children with severe acute malnutrition (SAM) have more than 3- fold risk of 
mortality compared to HIV uninfected children with SAM [76].  
In both HIV infected adults and children various macronutrient as well as 
micronutrient interventions have been studied to assess their effects on morbidity 
and mortality. However, currently no firm conclusions from intervention studies can 
be made on impact of macronutrient supplementation on morbidity and mortality in 
HIV infected individuals [77]. HIV infection is associated with multiple micronutrient 
deficiencies [78] such as vitamins, essential and trace element deficiencies. These 
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micronutrient deficiencies affect growth negatively [79] and  have been demonstrated 
even in apparently ambulant HIV infected children in Nigeria [78]. Micronutrient 
supplementation has been demonstrated to be safe and effective for reducing 
morbidity and mortality in HIV infected children [80]. Vitamin A supplementation 
reduced all-cause mortality by half in hospitalized Tanzanian HIV infected children 
with pneumonia [81] and Zinc reduced morbidity from diarrhea in HIV infected South 
African children [82]. In contrast, multiple micronutrient supplementation which 
contained several vitamins and micronutrients (Vitamins A, B1, B2, niacin, B6, B12, 
C, D and E, folate, zinc, copper, iodine and selenium) failed to reduce mortality, alter 
growth nor CD4 counts after 12 months in children below 5 years from Uganda [83]. 
Comparison was made of children on ART versus those who were not on ART. 
Multiple micronutrients however, reduced duration of hospital stay, micronutrient 
deficiencies and improved appetite in these children. Multiple micronutrient 
supplementation improved vitamin B12 and folate status in HIV infected children in 
Uganda [84]. As for iron supplementation, another common micronutrient deficiency, 
no conclusion has been reached yet on its impact on clinical, immunological and 
virologic outcomes in children infected with HIV [85]. 
 
1.2.3 Micronutrient Deficiencies 
Various micronutrient deficiencies accompany malnutrition [86, 87]. Iodine, Vitamin 
A, Iron, Zinc and folic acid are some of the common micronutrient deficiencies which 
can contribute to morbidity and mortality in under-nourished children. Studies have 
demonstrated that supplementing these deficient micronutrients is beneficial to both 
HIV infected and uninfected children under 5 years from the low income countries 
[88-90]. However, it has been demonstrated that HIV infected children from these 
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low income countries have a higher burden of multiple micronutrient deficiencies 
compared to their HIV uninfected peers [91] and this could worsen their health 
outcomes. Fortunately, studies are showing that supplementation of these 
micronutrient deficiencies is also beneficial to the HIV infected children. Targeted 
micronutrient supplementation may be useful in HIV infected children since some 
micronutrients such as iron are beneficial but may be associated with increased risk 
for malaria in endemic areas [92]. Hence, identification and treatment of these 
micronutrient deficiencies is important for children living in low income countries with 
an increased burden of under-nutrition co-existing with high prevalence of HIV 
infection. 
In Zimbabwe, the national micronutrient survey of 2012 [93] demonstrated quite 
significant multiple micronutrient deficiencies in children below 5 years of age. 
Nineteen percent of the under-fives had Vitamin A deficiency (retinol binding protein 
<0.825 μmol/litre and C-reactive protein ≤3mg/L), 72% had iron deficiency (ID) 
(soluble transferrin receptor (sTfR) >8.3μg/ml) and 24% had iron deficiency anaemia 
(IDA) (Haemoglobin <11g/dL and sTfR >8.3μg/ml). Under-five children living with 
HIV had higher prevalence of Vitamin A deficiency compared to the HIV uninfected 
children. Anaemic HIV infected children similarly had a higher prevalence of iron 
deficiency compared with their anaemic uninfected peers. Of note is that children 
between 5 and 12 years were only assessed for iodine deficiency and 37% had 
inadequate urinary iodine levels. Anthropometric measurements or assessment for 
Vitamin A status, Iron deficiency and IDA were not done in the children aged 5 to 12 
years. In addition, the ZDHS also restricts assessment of children’s nutritional status 
to under-fives [12]. Notably, nutrition programmes in low income settings including 
Zimbabwe have been focusing mainly on under-five children nutritional status 
 
 
26 
 
consequently resulting in limited information on the burden of malnutrition and on 
micronutrient status of school-aged children. This information would help guide 
policy formulation for nutrition programmes for children above 5 years in areas with a 
high prevalence of HIV infection in addition to a high burden of under-nutrition.  
1.2.3.1 Anaemia and Iron Deficiency 
Globally, iron deficiency is the commonest micronutrient deficiency resulting in 
anaemia in both adults and children [94]. Iron deficiency is a multisystem disorder 
with important health and economic effects. It negatively affects psychomotor 
development and cognitive function [95-97]. Iron deficiency results in abnormal 
neurone formation, myelination, neurotransmitter metabolism and changes in the 
hippocampus explaining its effects on brain development. Iron deficiency will cause 
irreversible changes during critical periods of brain growth in the first year of life 
[98].Despite this fact, research has shown that iron supplementation in non-anaemic 
iron deficient adolescent children improves verbal learning and memory [99]. It also 
has been associated with improved red cell indices and learning achievement in 
children of school age with iron deficiency anaemia [100].  
HIV infection has become an important cause of anaemia through several 
mechanisms especially in high HIV burden areas such as sub-Saharan Africa [101-
103]. The prevalence of anaemia and iron deficiency is unknown for HIV exposed 
and infected school children in Zimbabwe. Furthermore, the association of HIV 
infection or HIV exposure with anaemia in these school children is not well-defined. 
Improving iron status and general childhood nutrition would positively influence 
school performance [104]. 
 
 
 
27 
 
1.2.3.2 Selenium Deficiency 
Selenium deficiency is a less talked about micronutrient deficiency associated with 
under-nutrition and has not been clearly defined in school aged children from low 
income countries. Selenium is an essential micronutrient for human health [105]. It is 
an important component of the selenoproteins that have many functions in the body 
[105]. Selenium has an essential role in all aspects of the immune system: cell 
mediated and humoral functions [106, 107]. It is a potent antioxidant that protects the 
cell membrane and Deoxyribonucleic acids (DNA) [108, 109] safeguarding the body 
from many diseases. Animal studies on the mouse model have found a benefit of 
selenium on reducing Coxsackievirus B3 pathogenicity [110-113] and preventing 
cancer [114]. Observational studies in humans suggested a benefit of selenium in 
preventing cancer but randomized controlled trials have not demonstrated 
convincing evidence for selenium cancer prevention benefits [115]. Very few 
intervention studies found a benefit of selenium in preventing cancer in selenium 
deficient individuals [116, 117]. Selenium deficiency was associated with increased 
mortality and rapid disease progression in HIV infected adults who were intravenous 
drug users in the United States of America (USA) [118] and pregnant Tanzanian 
women [119]. Low serum selenium levels were associated with increased mortality 
of perinatally HIV infected children from the USA [120]. Low serum selenium levels 
were also associated with increased morbidity and mortality in Tanzanian children 
who were born to HIV infected women [121]. Higher baseline selenium levels were 
associated with lower HIV ribonucleic acid (RNA) in antiretroviral therapy (ART) 
naïve HIV infected children [122]. Selenium supplementation in HIV infected adults 
was also associated with suppression of HIV viral replication in a double blind 
randomized control trial [123]. Selenium daily supplements were associated with 
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reduced rates of hospitalisation and health related costs in HIV infected adults [124]. 
In contrast, selenium supplementation has been associated with negative outcomes 
in HIV infected individuals. Kupka et al reported increased HIV shedding in the 
cervico-vaginal secretions of Tanzanian women with serum selenium higher than 
114 micrograms per litre while Sudfeld et al reported  increased HIV detection in 
breast milk of primiparous Tanzanian women not on HAART [125, 126]. Further 
research is needed to define the impact of these findings on HIV transmission. 
However, since there are clear benefits of selenium, it then becomes important to 
assess selenium levels in children from settings with high burden of HIV infection 
and under-nutrition as this may provide evidence for a possible need of 
supplementation with this micronutrient. 
1.2.4 Macronutrient Deficiencies: Omega 3 Long Chain Polyunsaturated Fatty 
Acids (LCPUFA) 
Macronutrients are nutrients required in large quantities and provide energy for the 
human body. They include carbohydrates, proteins and fats. Fats are classified as 
saturated, monounsaturated and polyunsaturated. Long chain polyunsaturated fatty 
acid (LCPUFA) deficiency is an important macronutrient deficiency that accompanies 
malnutrition and may have a synergistic effect with the various micronutrient 
deficiencies on growth and neurocognitive development of children. Omega 3 fatty 
acids are LCPUFA essential to human health that are derived from alpha linoleic 
acid which comes from the diet [127]. The important metabolites of alpha linoleic 
acid include eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) [128]. 
They are anti- inflammatory [129-132], have an essential role of brain function, 
growth and development [133, 134]. Omega 3 fatty acid deficiency present with 
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symptoms that could partially explain the symptoms of under-nutrition such as 
growth failure, immunodeficiency and neurocognitive defects [135].  
Docosahexaenoic acid  and arachidonic acid which is an omega 6 fatty acid 
derivative are the main fatty acids in the brain [136]. DHA is an important constituent 
of the cell membrane and hence deficiency will affect many cellular functions 
especially in the brain [137]. Essential fatty acid deficiency can occur in under-
nutrition because of reduced intake, poor absorption, and reduced endogenous 
production of the LCPUFA from the parent molecule alpha linoleic acid resulting from 
poor enzyme activity [135]. In addition, the increased peroxidation that occur with 
under-nutrition because of associated antioxidant deficiencies especially selenium 
and vitamin E deficiency result in reduced levels of LCPUFA [135]. Under-nutrition in 
HIV uninfected children was associated with lower linoleic acid, arachidonic acid, 
DHA and reduced plasma plus red blood cell membrane LCPUFA [138-140]. Both 
under-nutrition and HIV infection may deplete LCPUFA from the cell membranes 
[141]. Reduced levels of DHA have been reported in under-nourished HIV infected 
children compared to under-nourished HIV uninfected children [140]. This could 
potentially exacerbate neurodevelopmental outcomes of malnourished children in 
association with zinc, iron, iodine and protein deficiencies. Moreover, the poor socio-
economic and psychological background that under-nourished children often live in 
worsen the neurodevelopmental outcomes [135]. HIV infection in well-nourished 
children on highly active ART (HAART) was associated with reduced alpha linoleic 
acid, high DHA and increased turnover of LCPUFA [142].  
Intervention studies have shown benefits of maternal and infant supplementation of 
omega 3 LCPUFA on neurocognitive development of younger children below five 
years [143]. This is most likely because the brain is rapidly growing and developing 
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before 2 years of age [144, 145]. Further brain development and maturation 
continues in childhood especially in the frontal lobe and the retina [145], therefore, 
omega 3 LCPUFA supplementation could also benefit older children. However, 
research in well children above 5 years has been equivocal in terms of improving 
neurocognitive outcomes. A single blinded randomised placebo controlled trial in 
south African children 7-9 years old who were supplemented with bread spread with 
marine fish flour giving a total DHA per week of 892mg for 6 months showed 
improvement in learning ability and memory [146]. However, the control group were 
more stunted, underweight and wasted than the intervention group and this possibly 
confounded the results as stunting is known to reduce cognitive function in children. 
In a double blind randomised placebo controlled trial which investigated effect of 
omega 3 supplementation (520mg) for 16 weeks in main stream school children from 
Wales who were aged 8-9 years and had intelligent quotient ≥70 showed that omega 
3 fatty acid status improved with minor differences in cognitive and behavioural 
outcomes [147]. The intervention group had greater accuracy on a test of impulsivity 
and supplementation had a protective effect on pro-social behaviour. However, the 
supplementation period may have been too short to show significant differences in 
children now experiencing slow brain growth and the cheek cell polyunsaturated fatty 
acids (PUFA) status used to assess omega 3 status may reflect recent intake but not 
mirror well the brain PUFA status. In contrast, the CHAMPION study which 
investigated 6 to 10 year old Indian children who were supplemented with LCPUFA 
and micronutrients found no effect on cognitive performance [148]. However, the 
children had high prevalence of micronutrient deficiencies including IDA, too low 
doses of DHA below the recommended daily allowance were used and no placebo 
was used. Australian and Indonesian children (the NEMO study) children were 
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randomised to micronutrients, LCPUFA, both or placebo. There were no effects 
attributed to LCPUFA supplementation though the micronutrients improved height 
and short term memory. Too low doses of DHA and EPA were administered and 
there was a high prevalence of IDA [149]. DHA did not modify cognitive performance 
in 10 to 12 year old children from Newcastle, England. The children were recruited in 
a double blind placebo controlled randomised trial and were supplemented with 
1000mg DHA, 400mg DHA or placebo for 8 weeks. Limitations included a small 
sample size, lack of biochemical confirmation of adherence and the short duration of 
intervention period [150]. Nevertheless, in children above 5 years who are unwell 
with phenylketonuria and psychiatric disorders, supplementation with omega 3 
LCPUFA has been shown to be beneficial [151-153]. In addition, an Italian study that 
pooled data from four cohorts of participants showed that from the neonatal period to 
adulthood, children had the lowest level of LC-PUFA [154]. It then becomes very 
important to determine the levels of omega 3 LCPUFA in children from settings with 
dual burden of under-nutrition and HIV infection as omega 3 LCPUFA 
supplementation could potentially mitigate some of the effects of micronutrient 
deficiencies such as iron deficiency on cognitive function and the immune system in 
malnourished HIV infected, HIV exposed and HIV uninfected school aged children 
from resource limited settings. 
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1.3 JUSTIFICATION 
Under-nutrition remains a problem in school aged children from low income countries 
particularly those with a high burden of HIV infection. Under-nutrition is associated 
with multiple micronutrient deficiencies that result in short and long term effects of 
great consequence to the individual affected and the society. 
Zimbabwe just like many low income countries in Sub-Saharan Africa is affected by 
the dual burdens of under-nutrition and HIV infection. Nutrition programmes in 
Zimbabwe are focusing on the first 1000 days of life as evidence has shown that 
interventions targeting this age group are cost effective in reducing the burden and 
consequences of under-nutrition. However, this has resulted in nutrition programmes 
overlooking children above 5 years. Importantly, nutritional surveys including the 
Zimbabwe National Demographic Health and the Micronutrient Surveys do not 
assess nutritional status of children above 5 years. This has resulted in limited 
information on children above 5 years’ nutritional and micronutrient status.  
Information on the nutritional and micronutrient status of children above 5 years may 
assist policy makers when designing their nutrition programmes and will allow 
targeted interventions to address micronutrient deficiencies especially for HIV 
exposed and infected children in this age group. This becomes extremely important 
especially with the growing numbers of HIV exposed children in the country following 
the success of the prevention of mother-to-child transmission of HIV infection 
(PMTCT) programmes. In addition, assessing the nutritional and micronutrient status 
of HIV uninfected children above 5 years in low income countries will also provide 
useful information for planning appropriate nutrition programmes for these children.  
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1.4 THE RESEARCH QUESTION 
What is the iron, selenium, omega 3 fatty acid and nutritional status of the children 
aged 7 to 10 years who were born in the Better Health for African Mothers and 
Children (BHAMC) study, a PMTCT cohort? 
1.4.1 Objectives 
Primary:  To measure prevalence of malnutrition, anaemia, iron deficiency, selenium 
deficiency and describe the omega 3 fatty acid status in HIV unexposed and HIV 
exposed (infected and uninfected) children 7 to 10 years old who were born in a 
national PMTCT programme (BHAMC study) from a peri-urban setting in Zimbabwe, 
a low income country with a high burden of HIV infection. 
1.4.2 Secondary Objectives: 
1. To measure the prevalence and factors associated with stunting, thinness, 
overweight, underweight and selenium deficiency in children 7 to 10 years old.  
2. To determine the prevalence and factors associated with anaemia and iron 
deficiency in 7 to 10 years old HIV infected and uninfected children using 
haemoglobin, serum ferritin and soluble transferrin receptor levels.  
3. To determine and compare omega 3 fatty acid levels in 7 to 10 years old HIV 
unexposed and exposed children using whole blood dry blood spot samples.  
 
1.4.3 The Study Factors 
The HIV status (infected, exposed uninfected and unexposed uninfected) of the 7 to 
10 year old children is the main study variable. The children’s gender, age, orphan 
hood status, household income and clinic site were the other study factors.  
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1.4.4. The Outcome Variables 
The main outcome measures were the nutritional status of the children (stunting, 
thinness, underweight, overweight), haemoglobin, serum Ferritin, soluble transferrin 
receptor (sTfR), serum selenium and whole blood omega 3 fatty acids 
[Eicosapentaenoic acid (EPA), Docosapentaenoic acid (DPA) and docosahexaenoic 
acid(DHA)]. 
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2. MATERIALS AND METHODS 
 
2.1 Study Population and Setting 
This cross-sectional study was carried out from August 2011 to June 2012 at 3 peri-
urban primary care clinics (Epworth, St Mary’s and Seke North Clinics) in Zimbabwe. 
Epworth clinic is located in a much poorer community compared to Chitungwiza 
community where St Mary’s and Seke North Clinics are located. Epworth is also in a 
different geographical location and falls under a separate administrative area from 
the Chitungwiza sites. The participants were 7-10 years old school aged children 
whose mothers had been recruited into a PMTCT programme from 2002 to 2004. 
This was a sub-study in the BHAMC study which investigated the role of sexually 
transmitted infections on vertical transmission of HIV and is described elsewhere 
[155]. Briefly, the BHAMC study recruited women 36 weeks pregnant coming 
through the national PMTCT programme who underwent voluntary counselling and 
HIV testing. Hence the cohort of children comprised of HIV negative unexposed, HIV 
negative exposed and HIV infected children. HIV negative unexposed children are 
HIV uninfected children who were born to HIV negative women. HIV negative 
exposed children were born to HIV positive women but are HIV uninfected. HIV 
infected children were born to HIV infected women and became HIV infected. HIV 
test results available from a previous study were used to define the HIV infection 
status of the children [156]. Children were tested for HIV infection using HIV DNA 
PCR at birth, 6 weeks, 4 months and 9 months. After 18months, testing was done 
using Enzyme linked immunoassay (ELISA) and Western Blot. 
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2.1.1 Inclusion and Exclusion Criteria 
All children between 7 and 10 years who were still alive from the BHAMC cohort at 
the time of the study, whose care givers consented to be included in the study, were 
eligible for recruitment. The second siblings to the original cohort of children were 
excluded.  
 
2.1.2 Sample Size Calculation 
The sampling frame is shown in figure 3. The prevalence of malnutrition (p): stunting, 
thinness, overweight and underweight in this group of children was unknown and 
estimated to be 50%. The minimum sample size required for estimating the 
prevalence of malnutrition in this population of children with a confidence interval of 
95% (significance level; z) and a margin of error (se) of 0.05 was calculated to be 
208 using the Raosoft® sample size calculator. The calculation is based on the 
following formula: 
݊ ൌ ݖଶሾ݌ሺͳ െ ݌ሻሿȀݏ݁ଶ 
It was also assumed that the prevalence of anaemia and selenium deficiency were 
50% since they were unknown for this particular population of children between 5 
and 10 years of age from Zimbabwe. The minimum sample size required for 
estimating both the prevalence of anaemia and selenium deficiency in this population 
of children was calculated to be 208. 
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Figure 5 The Sampling Frame for 7 to 10 year old children from the 1050 
mother-baby pairs in the BHAMC cohort, Zimbabwe 
 
Adapted from Kurewa et al, 2011 
The original birth cohort had 1050 babies born to 571 HIV negative and 479 HIV 
positive mothers. However, during the planning stage of this study, only 237 babies 
born to HIV negative mothers and 215 born to HIV positive mothers could be traced 
for possible recruitment into the study. The rest had either been lost to follow up or 
had died [155]. A decision to include more than the 208 children was made to aid the 
assessment of iron, omega 3 fatty acids and selenium status of the children whose 
prevalence’s were unknown for this Zimbabwean population of children and had 
been estimated to be 50%. Caregivers in the community were contacted by peer 
counsellors and were informed about the study. Participants were consecutively 
recruited as they presented to the local clinic every Thursday between 8am and 
6pm. 
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2.2 Data Collection 
A questionnaire designed to collect data was piloted, modified and then was 
administered to collect socio-demographic data including age, gender, household 
monthly income, primary care giver (defined as person who took care of the child 
during most of the day) and whether parents of the child were alive. All the study 
personnel were trained to use the data collection tool in order to standardize data 
collection. All the children had a complete physical examination performed by the 
study paediatrician. Children were treated for illness identified during the physical 
examination. Height, weight, occipital-frontal (head) circumference and MUAC were 
measured. The children’s weight was measured once while they put on light clothing 
with a Seca digital scale (manufactured in Germany model: 881 1021659) which was 
calibrated daily. A stadiometer was used to measure height once. The children took 
off their shoes, stood feet together with the heels against the wall and looked straight 
ahead. One person would ensure the correct head position and another person 
ensured that the knees were extended while the heels touched the back of the wall. 
The head circumference was measured in the occipital-frontal diameter with a non-
stretchable tape measure. The measurement was repeated three times and the 
largest measurement was taken as the head circumference. The MUAC was also 
measured once in the non-dominant arm. The midpoint between the shoulder and 
the elbow was determined with flexible non-stretchable tape. The MUAC was then 
measured with the limb hanging down and relaxed. The WHO’s Anthroplus software 
(version1.0.4) was used to calculate Z scores for body mass index, weight for age 
and height for age. The WHO recommended Z score cut-offs for underweight, 
stunting and thinness were used to define under-nutrition. Z scores below -2 and -3 
were considered as moderate and severe under-nutrition respectively. Children with 
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a BMI Z-score below -3 for age were classified as SAM. Overweight and obesity 
definitions used are as shown in Table [29]. 
 
Table 3 Definition of Terms 
Characteristic Indicator 
Stunting Height-for-age Z score < -2 
Severe Stunting Height-for-age Z score < -3 
Underweight Weight-for-age Z score < -2 
Severe Underweight Weight-for-age Z score < -3 
Thinness BMI-for-age Z score < -2 
Severe Thinness BMI-for-age Z score < -3 
Overweight BMI-for-age Z Score ≥1 and<2 
Obesity BMI-for-age Z Score ≥ 2 
Selenium deficiency Serum Selenium <0.89μmol/L 
Anaemia Hb <11.5 g/dl 
Iron Deficiency Serum Ferritin (F) 15 μg/L 
Iron Deficiency Anaemia Hb <11.5 g/dl AND F <15 μg/L OR sTfR >8.3 μg/L 
BMI-for-age Body mass index-for-age; Hb Haemoglobin; F Ferritin;  
sTfR Soluble Transferrin Receptor 
Source: Cole et al, 2007; WHO, 2008; Amare et al, 2012 
 
2.2.1 Blood Samples Collection 
2.2.1.1 Haemoglobin Determination 
Participants’ hands were washed thoroughly with soap, rinsed well with warm water 
and dried with paper towel. The middle finger was massaged and a lancet was 
pressed on the fleshy part of the finger tip. The finger was gently squeezed to 
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produce a drop of blood. The initial drop of blood was wiped away with cotton wool. 
Blood was collected in a micro cuvette slide and the haemoglobin level was 
determined using a battery powered HemoCue photometer. The photometer uses 
the azide-methemoglobin method for determining haemoglobin concentration [157]. 
Anaemia was defined as a haemoglobin level of less than 11.5 grams per decilitre 
(g/dl) and a classification proposed by WHO was used to interpret the public health 
significance of the prevalence as shown in Table 4. 
 
Table 4 Classification of Prevalence of Anaemia in Populations Based on 
Haemoglobin Level[158] 
Prevalence of Anaemia  Category of Public Health Significance 
≤4.9 % No Public Health Problem 
5.0-19.9 % Mild Public Health Problem 
20.0-39.9 % Moderate Public Health Problem 
≥40.0 % Severe Public Health Problem 
Source: WHO, 2001 
 
2.2.1.2 Dry Blood Spot for Omega 3 Fatty Acids Determination 
The subsequent drops of blood were collected on filter paper by allowing blood to 
touch the filter paper inside a marked circle without smearing it so that blood was 
drawn onto filter paper by capillary action. This was repeated until four circles were 
filled with blood. The back was checked to ensure it looked like the front. This 
procedure can be viewed on the web page as described by the Institute of 
Aquaculture, University of Stirling in Scotland [159]. The filter paper was then air 
dried away from the sun at room temperature for at least 3 hours. It was then 
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packaged in foil paper with desiccant and sealed. The filter papers were then stored 
in a freezer at -20 ᵒC until shipping under the same conditions to a laboratory testing 
site in Scotland. 
 
2.2.1.3 Blood Collection for Serum Ferritin, Soluble Transferrin Receptor and 
Selenium Levels Determination 
The skin was wiped with a methylated spirit-soaked swab and allowed to air-dry for 
one minute. A tourniquet was applied above the elbow joint and using appropriate 
protective equipment, blood was collected by venipuncture into a red top plain tube 
(4ml) and a royal blue top trace element tube (5ml). Care was taken to prevent 
haemolysis of the samples. The specimens were immediately stored in a cooler box 
at a temperature between 2 and 8ᵒC for transportation to the laboratory where they 
were spun for 10 minutes at 1100 revolutions per minute. At least two 1ml aliquots of 
serum from both the red and royal blue top tubes were stored at -80 ᵒC. The 
specimens were temporarily stored in a local bio bank. One aliquot from the blue top 
tube was shipped on blue ice to Fürst Medical laboratory in Norway for selenium 
determination. Determination of serum ferritin and soluble transferrin receptor (sTfR) 
levels was done in a local laboratory: the University of Zimbabwe - University of 
California, San Francisco (UZ-UCSF) laboratory.  
 
2.3 Laboratory Analyses 
2.3.1 Serum Ferritin and Soluble Transferrin Receptor Levels 
Enzyme immunoassays for the quantitative analysis of serum ferritin [RAMCO 
LABORATORIES INC., Stafford; USA] [160] and sTfR levels [RAMCO 
LABORATORIES INC., Stafford; USA] [161] were used to determine serum ferritin 
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and soluble transferrin receptor levels in the children respectively. The manufacturer 
provided software to calculate the actual amount of serum ferritin and serum 
transferrin receptor levels from the derived absorbance. ID was defined as a serum 
ferritin level of less than 15 micrograms per litre (μg/L). IDA was defined as a 
haemoglobin level of less than 11.5 g/dl and either ferritin below 15 μg/L or a soluble 
transferrin receptor level of more than 8.3 μg/L (above manufacturer’ reference limit). 
Serum ferritin levels were measured in all children. Only children with ferritin levels 
ranging between 15 and 50 μg/L and who had haemoglobin less than 11.5 grams 
per decilitre with ferritin above 15 μg/L had their sTfR level measured. This was done 
to identify children who had ID but had ferritin above the cut off value raised falsely 
because of inflammation, since the study setting is an area of high infectious disease 
burden. 
 
2.3.2 Serum Selenium Determination 
Automated inductively coupled plasma mass spectrometry was used to measure 
serum selenium levels. A PerkinElmer Sciex; Elan£ DRC™ II (Manufactured 2005 
Shelton, USA) spectrometer was used. The mass spectrometer generated single 
charge ions from elements in the sample. The ions were then separated based on 
mass-to-charge ratio and then detected. Internal and external calibrators were used 
for quality control as recommended by the manufacturer. There is no clearly set 
definition for selenium deficiency in this age group of children. However, in this study 
selenium deficiency was defined as a value below 0.89 μmol/ litre and this was 
based on studies from Vietnam [162] and Ethiopia [163] in children of a similar age 
group. These studies’ definition was used to enable comparison of results since 
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there are limited studies of selenium deficiency in children and selenium levels 
above this cut off are associated with favourable health outcomes [164].  
 
2.3.3 Omega 3 Fatty Acids Determination 
Omega 3 fatty acids analysis was performed at the Nutrition Group Laboratory at the 
Institute of Aquaculture, University of Stirling in Scotland. A method described by Bell 
et al [165] was used to measure whole blood phospholipids from dry blood spots on 
filter paper treated with butylated hydroxytoluene (Sigma Aldrich Limited, Gillingham 
Dorset, United Kingdom). Automated gas liquid chromatography was used for 
analysis. Results were reported as percent by weight of each fatty acid to total fatty 
acids. The omega 3 polyunsaturated fatty acids: EPA, Docosapentaenoic acid (DPA) 
and DHA were selected for data analysis. 
 
2.4 Ethics Statement 
This study was approved by the local authorities in Chitungwiza (Seke North and St 
Mary’s Clinics) and Mashonaland East Province (Epworth clinic), Medical Research 
Council of Zimbabwe, Research Council of Zimbabwe and the Norwegian Research 
Ethics Committee. After the study was explained to the participants, the care givers 
gave written informed consent and the children gave written assent to be included in 
the study. It was clearly explained to caregivers that refusing to participate in the 
research would not prejudice them in anyway and they would still be able to get the 
best care for their children at the clinics. Consent to allow storage of specimens in a 
local bio-bank and shipping of specimens to laboratory testing sites outside 
Zimbabwe during the study period were also obtained from the care givers. It was 
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also highlighted that it was their right to refuse storage or shipment of specimens to 
another country. In addition, permission to ship specimens to Scotland and Norway 
for determination of omega 3 fatty acids and selenium levels respectively was 
obtained from the Research Council of Zimbabwe. International standards for 
shipping specimens were applied. Data collection tools and the consent forms were 
translated to the local Shona language. Data was made anonymous by using study 
identification numbers. The data forms were stored separately from the participants’ 
identities and were only accessible to the study team. 
Participants and their care givers had their travel costs fully reimbursed. They were 
offered standard of care for co-morbid conditions detected during the physical 
examination. The study provided essential drugs for community management of 
common childhood illnesses. Children with SAM were managed according to the 
Ministry of Health and Child Care protocol for treating SAM in children above 5 years 
with RUTF [166]. The children were discharged from follow up once their BMI Z-
score was above -2 or after 4 months in the programme. Those who did not improve 
were referred to the provincial hospital for further investigation and treatment. 
Anaemic children were given iron supplements for two months and those with severe 
anaemia (below 7g/dl) were referred to the district hospital for further investigation 
and treatment. All HIV infected children were on trimethoprim-sulphamethoxazole 
prophylaxis. They were accessing care and treatment for HIV infection from the local 
governmental and non-governmental HIV clinics.  
2.5 Statistical Analyses 
Data was double entered into a computer using the CSPRO package. Data was 
cleaned and the SPSS statistical package [IBM SPSS Statistics version 20.0.0.1] 
was used for statistical analysis. A p-value less than 0.05 was considered statistically 
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significant. Descriptive statistics and prevalence calculations were used to describe 
the data. Correlation was used to describe continuous data. Chi square and fisher’s 
exact tests were performed to determine associations between categorical data for 
example; to investigate associations between anaemia and the categorical 
characteristics of the participants. Pearson’s chi-square and risk estimates were 
used to determine the odds of detecting anaemia in HIV infected and HIV uninfected 
children. Spearman correlation was used to investigate relationships between 
haemoglobin and the participants’ continuous characteristics. 
The one-way Anova test and the Boniferroni post-hoc test were used to compare 
means of continuous outcome variables (anthropometric measurements and 
selenium) according to the HIV status of the children. These tests were used to 
describe the factors associated with malnutrition and selenium deficiency. The 
Kruskal-Wallis test as well as the Medians test were used to compare distribution 
and medians of omega 3 fatty acids: EPA, DPA and DHA among the HIV infected, 
HIV exposed uninfected and HIV unexposed uninfected children as the omega 3 
fatty acid data was not normally distributed. 
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3.  RESULTS 
3.1 Demographic Characteristics of the Participants 
A total of 318 children were recruited in the study out of a possible 452 children. Of 
the 134 children that were not recruited; the majority had been lost to follow up, 23 
refused to participate in the study and 1 child from St Mary’s clinic refused to assent 
as he did not want to have blood drawn from him. The ‘lost to follow up’ group 
included an unknown number of participants whose families had relocated from the 
area of study. 
The primary caregiver was the mother for 71% of the children and 19% were being 
looked after by their grandmothers. Very few (4%) primary care givers had not gone 
to school while 64% had gone up to secondary school. Majority of the working 
mothers (93%) were informally employed with 38% working as vendors. Fifty seven 
per cent of the mothers were married, 9% had remarried and 9% were divorced. 
Seventy five percent of the children’s fathers were alive and 52% of the children 
were living with their fathers in the same household. A third of the children were 
orphaned with 5% being double orphans (both parents deceased). Table 5 shows 
the socio-demographic features of the children. 
Majority of the children were HIV negative unexposed (57%). One child had no 
confirmed HIV status hence was excluded from the analysis requiring HIV infection 
status. This child was lost to follow up soon after birth only to return to the study area 
during the study period. The child’s caregiver was advised to get the child tested for 
HIV as the child was exposed at birth. The prevalence of HIV infection in the cohort 
was 7%. The 9 and 10 year age groups where combined because there were only 
three children in the 10 year age group. There were more children recruited from 
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Epworth (85%) and St Mary’s (83%) clinics living in households with monthly 
incomes less than or equal to $250 (p <0.0001). However, there were no statistically 
significant differences in gender, orphan hood and HIV status distribution of the 
children by clinic site of recruitment. 
3.2 Nutritional Status and Serum Selenium Levels 
The anthropometric measurements of the participants are shown in Table 6. There 
were six children whose head circumference and mid-upper arm circumference 
values were missing. The mean Z scores of the weight for age, height for age and 
BMI for age were all between 0 and -1. Stunting was the commonest form of under-
nutrition occurring in 12% of the children as shown in Table 7. Three children met the 
WHO criteria for diagnosis of severe acute malnutrition and were managed with a 
ready-to-use therapeutic food. Only one HIV uninfected child failed to recover after 4 
months of community based treatment for severe acute malnutrition and required 
referral for further management at the provincial hospital. Only 269 out of 318 
children had their serum selenium values determined because trace element tubes 
expired before the study was completed. Almost half of the children who had their 
serum selenium levels measured were classified as selenium deficient using the 
protocol definition. 
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Table 5: The Socio-demographic Characteristics of 318 Zimbabwean School 
Children Aged 7-10 years (Paper 1) 
Characteristic Description Frequency  
Age Group   
 7 years 21 (7%) 
 8 years 105 (33%) 
 9 years 189 (59%) 
 10 years 3 (1%) 
Gender   
 Male 137 (43%) 
 Female 181 (57%) 
HIV status Negative unexposed 180(57%) 
 Negative exposed 116(36%) 
 Positive 21(7%) 
 Unknown 1(0.3%) 
Orphan hood Double orphan 15(5%) 
 Single orphan 79(25%) 
 Not orphaned 224(70%) 
Primary Caregiver N=318  
 Mother 226 (71%) 
 Grandmother 59 (19%) 
 Sibling 5 (5%) 
 Other 28 (9%) 
Primary Caregiver’s 
Education 
  
 No School 11 (4%) 
 Primary level (≤ 7 years) 93 (29%) 
 Secondary Level ( 8-13 
years) 
205 (64%) 
 Diploma or Degree 7 (2%) 
 Unknown 2 (1%) 
Mother’s Occupation N=285  
 Formal 20 (7%) 
 Informal 265 (93%) 
Household   
Monthly income US$ 
median(Q1;Q3) 
N=268 150 (80;250) 
Total number of people 
living in the household 
median(Q1;Q3) 
N=318 5 (4;6) 
Number children below 10 
years median (Q1;Q3) 
N=316 2 (1;3) 
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Table 6: The Mean Values of Anthropometric Measurements and Serum 
Selenium Levels of 318 7-10 Year Old Children from Zimbabwe (Paper 1) 
Characteristic Frequency 
N 
Mean (±SD*) Minimum Maximum 
Height cm 318 127(±6.9) 104 149 
Weight kg 318 25(±3.8) 15 42 
Head Circumference cm 312 52(±1.6) 47 57 
Mid-upper arm 
circumference mm 
312 180(±15.6) 120 230 
Weight-for-age Z score 317 -0.77(±0.93) -4.97 1.72 
Height-for-age Z score 318 -0.88(±1.03) -4.96 1.96 
BMI-for-age Z score 318 -0.38(±0.88) -3.32 1.76 
Serum Selenium value 
μmol/L 
269 0.85(±0.16) 0.30 1.60 
* Standard Deviation 
Children from households with a monthly income of less than US$250.00 and from 
Epworth clinic had a higher prevalence of selenium deficiency as shown in Table 8. 
There was no statistically significant difference in selenium levels among the children 
according to their HIV status. Stunting was associated with HIV exposure and 
orphan hood.  
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Table 7: Prevalence of Stunting, Underweight, Thinness, Overweight and 
Selenium Deficiency (Serum Selenium <0.89μmol/L) among 318 School 
Children from Zimbabwe (Paper 1) 
Characteristic Indicator Frequency n (%) 
Stunting Height-for-age Z score < -2 37(12) 
 Height-for-age Z score < -3 7(2) 
Underweight Weight-for-age Z score < -2 25(8)1 
 Weight-for-age Z score < -3 4(1) 
Thinness BMI-for-age Z score < -2 11(4) 
 BMI-for-age Z score < -3 3(1) 
Overweight BMI-for-age Z Score ≥1 and<2 15 (5) 
Selenium deficiency Serum Selenium <0.89μmol/L 129 (48)2 
1 N = 317 children 
2 N = 269 children 
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Table 8: Factors Associated with Stunting, Thinness, Overweight, Underweight 
and Selenium Deficiency in 318 7-10 Year Old Children from Zimbabwe (Paper 
1) 
Characteristic Frequency Stunting Thinness Overweight Underweight1 Selenium 
deficiency2  
       
  n (%) n (%) n (%) n (%) n (%) 
Gender       
Male 137 19(14) 5(4) 8(6) 12(9) 54(45) 
Female 181 18(10) 6(3) 7(4) 13(7) 75(50) 
Age       
7 years 21 5(24) 2(10) 0 1(5) 8(38) 
8 years 105 12(11) 4(4) 4(4) 9(9) 48(53) 
9-10 years 192 20(10) 5(3) 11(6) 15(8) 73(46) 
Clinic       
Epworth 104 14(13) 3(3) 7(7) 9(9) 45(62) * 
St Mary’s 104 12(12) 4(4) 3(3) 11(11) 40(41) 
Seke North 110 11(10) 4(4) 5(5) 5(5) 44(45) 
Household monthly 
income  
      
≤$250 205 26(13) 8(4) 12(6) 3(5) 96(54)* 
> $250 63 6(10) 1(2) 1(2) 20(10) 15(33) 
HIV status       
Negative 
Unexposed 
180 12(7) 5(3) 10(6) 15(8) 63(43) 
Negative Exposed 116 17(15) ** 4(3) 5(4) 8(7) 53(52) 
Positive 21 8(38) ** 2(10) 0 2(10) 13(62) 
Orphan hood       
Not orphaned 224 20(9) 6(3) 14(6) 18(8) 97(50) 
Orphaned 94 17(18)* 5(5) 1(1) 7(7) 32(42) 
Total 318 37(7) 11(4) 15(5) 25(8) 129(48) 
*p value < 0.05  **p value <0.001 
Analysis done with One-way ANOVA and Boniferroni post hoc test 
1 N=317 
2 N=269 
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Obesity was not detected in this group of children and no overweight children were 
stunted. Two of the stunted children also had thinness. Of the 37 stunted children, 16 
(43%) were also underweight for age. HIV infected children were 7.5cm shorter than 
the HIV uninfected unexposed children (p= 0.00). The HIV infected children were 
also 5.4cm shorter than the HIV uninfected exposed children (p=0.00). There was no 
significant difference in mean weight of the HIV uninfected (unexposed and exposed) 
children. However, HIV infected children were 3.5kg lighter than the HIV uninfected 
unexposed children (p=0.00) and were 2.7kg lighter than the HIV uninfected exposed 
children (p=0.01). There was no statistically significant difference in head 
circumference among all the children according to their HIV status. HIV uninfected 
unexposed and HIV uninfected exposed children had MUAC size longer than that of 
children with HIV infection by 11 mm (p=0.01) respectively.  
3.3 Prevalence of Anaemia and IDA 
The mean haemoglobin and ferritin stratified for age, gender, maternal and children’s 
HIV status are presented in Table 9. One child did not have results for haemoglobin. 
Two children did not have serum ferritin results. One hundred and ninety children 
who had met the study criteria had their sTfR levels measured. The prevalence of 
all-cause anaemia in the children was 15% (n= 48) and that of IDA was 2%. There 
was no difference in the prevalence of all-cause anaemia between the girls and boys 
(p = 0.94). Only one child had severe anaemia of 4.4 g/dL and further investigation at 
the provincial hospital showed that this child had sickle cell anaemia. The prevalence 
of ID was 4%. The WHO recommends using a higher cut off level for ferritin of 30 
μg/L in children below five years in areas with a high infectious disease burden. 
However, there is no recommendation for children above five years in comparable 
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settings. When the higher cut off for ferritin was applied (Table 10), it resulted in 
higher prevalence of ID (32%) and IDA (5%). Anaemia was more likely to be present 
in HIV infected children (p-value<0.001) with an odds ratio of 4.9 (CI 1.9- 12.4). The 
maternal HIV status at birth was not related to presence of anaemia in the children 
aged 7 to 10 years. 
Table 9: Haemoglobin, Ferritin, All-cause Anaemia (ACA) and Iron Deficiency 
Anaemia (IDA) Stratified for Gender, Age and HIV Status in Zimbabwean 
School-aged Children (Paper 2) 
Characteristic Subcategory Frequency 
(n) 
¹Haemoglobin  
(g/dl)  
n = 317 
²Ferritin 
(μg/L)  
n = 316 
ACA 
n (%) 
IDA3 
n (%) 
Gender Female 181 12.5(±1.10) 46.1(±26.5) 27(15) 2(1) 
 Male 137 12.5(±1.23) 47.2(±39.5) 21(15) 5(4) 
Age (years) 7 21 12.7(±1.04) 48.3(±25.2) 3(14) 0(0) 
 8 105 12.4(±1.08) 48.8(±41.7) 21(20) 2(2) 
 9 186 12.6(±1.19) 45.3(±27.7) 23(12) 5(3) 
 10 6 12.3(±1.42) 41.8(±24.5) 1(17) 0(0) 
HIV status Negative 
unexposed 
179 12.7(±1.0) 49.5(±37.6) 18(10) 2(1) 
 Negative 
exposed 
116 12.4(±1.3) 42.1(±24.0) 21(18) 4(3) 
 Positive 21 11.9(±1.3) 51.0(±34.0) 9(43) 1(5) 
 Total 316 12.5(±1.16) 46.6(±32.7) 48(15) 7(2) 
¹ Mean haemoglobin (standard deviation) 
² Mean ferritin (standard deviation) 
3 IDA defined as Hb < 11.5 g/dl and either F < 15 μg/L or sTfR level > 8.3 μg/L 
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Table 10: Prevalence of Iron Deficiency (ID) and Iron Deficiency Anaemia (IDA) 
Using a Ferritin Cut-Off Value of 15μg/L and 30μg/L Respectively in 7-10 Year 
Old Zimbabwean Children Stratified by Age, Gender and HIV Status (Paper 2) 
Characteristic  Frequency 
n 
ID 
F<15μg/L 
n (%) 
ID 
F<30μg/L 
 n (%) 
IDA1 
F<15μg/L  
n (%) 
IDA2 
F<30μg/L 
n (%) 
Gender Female 179 7(4) 50(28) 2(1) 6(3) 
 male 137 6(4) 52(38) 5(4) 10(7) 
Age group       
 7 years 20 0(0) 5(25) 0(0) 0(0) 
 8 years 105 5(5) 31(30) 2(2) 5(5) 
 9-10 years 191 8(4) 66(35) 5(3) 11(6) 
HIV Status       
 Negative 
unexposed 
179 5(3) 57(32) 2(1) 8(4) 
 Negative 
exposed 
115 8(7) 40(35) 4(3) 7(6) 
 Positive 21 0(0) 4(19) 1(5) 1(5) 
Total  316 13(4) 102(32) 7(2) 16(5) 
1 IDA defined as Hb < 11.5 g/dl and either F < 15 μg/L or sTfR level > 8.3 μg/L 
2 IDA defined as Hb < 11.5 g/dl and either F < 30 μg/L or sTfR level > 8.3 μg/L 
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3.4 Omega 3 Fatty Acid Levels 
There were no statistically significant differences among the children’s EPA, DPA 
and DHA levels (medians and distribution) according to their HIV status, gender and 
nutritional status as shown in Table 11. However, there was a statistically significant 
difference in the EPA medians by age group (p=0.02). The 7 year old age group had 
the lowest median compared to the 8 and 9 year old age groups. However, this age 
group only had 21 participants. 
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Table 11: The Whole Blood EPA, DPA and DHA Levels of 7-10 Years Old 
Children from a Peri-Urban Area in Zimbabwe Stratified by HIV Status, Age, 
Gender and Nutritional Status (Paper 3) 
Characteristic N EPA1 
Median(IQR) 
p-
value2 
DPA1 
Median(IQR) 
p-
value2 
DHA1,2 
Median(IQR) 
p-
value2 
Age group        
7 years 21 0.17 (0.03) 0.02* 0.75(0.18) 0.38 2.09(0.49) 0.56 
8 years 105 0.20 (0.10)  0.81(0.21)  2.18(0.59)  
9-10 years3 192 0.18 (0.08)  0.78 (0.18)  2.11 (0.52)  
Gender        
Female 181 0.19 (0.08) 0.37 0.78 (0.20) 0.26 2.16 (0.50) 0.82 
Male 137 0.18 (0.08)  0.81 (0.18)  2.11 (0.60)  
Stunting        
Yes 37 0.18 (0.84) 1.00 0.80 (0.24) 1.00 2.14 (0.54) 0.73 
No 281 0.19 (0.09)  0.79 (0.18)  2.12 (0.52)  
Underweight        
Yes 25 0.17 (0.07) 0.99 0.77 (0.13) 0.99 2.04 (0.52) 0.22 
No 292 0.19 (0.08)  0.79 (0.19)  2.14 (0.55)  
Thinness        
Yes 11 0.17 (0.07) 0.54 0.71 (0.18) 0.54 2.08 (0.39) 0.54 
No 307 0.19 (0.09)  0.79 (0.19)  2.14 (0.56)  
HIV Status        
HIV unexposed 
uninfected 
180 0.19(0.08) 0.40 0.80(0.18) 0.76 2.11(0.55) 0.44 
HIV exposed 
uninfected 
116 0.18(0.09)  0.79(0.18)  2.16(0.50)  
HIV infected 21 0.19(0.12)  0.79(0.25)  2.07(0.65)  
Total 3174 0.19 (0.09)  0.79 (0.19)   2.14 (0.54)  
*Significant p-value less than 0.05 
1Measured as % weight of Total serum phospholipids (% wt/wt) 
2The Median test was used to compare medians across groups 
3Combined the 9 and 10 year olds because there were only 3 children 10 years old  
4One child’s HIV status from the 318 children was unknown. 
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4. DISCUSSION 
Majority of the children who participated in this study were HIV negative either 
unexposed or exposed. The prevalence of HIV infection of 7% documented in this 
study is above the reported national prevalence for children below 15 years from 
Zimbabwe, which for the year 2014 was 2.7% [15]. The highest recorded prevalence 
of HIV infection for children below 15 years (3.05%) was reported in the 2005 [15]. 
The BHAMC cohort is a highly selected population of children whose prevalence of 
HIV infection cannot be generalized to the prevalence of HIV for children below 15 
years in Zimbabwe. This can be explained by the methodology of the BHAMC cohort 
[156] where active recruitment of HIV infected pregnant women was deliberate so 
that there were adequate numbers to address questions on mother-to-child 
transmission of HIV.  
4.1 Paper 1- Nutritional Status and Selenium Deficiency 
4.1.1 Stunting, Wasting, Underweight and Overweight/Obesity 
The prevalence of stunting of 12% among 7 to 10 years old HIV exposed (infected 
and uninfected) and HIV unexposed uninfected children in this study demonstrated is 
regarded as of mild public health significance according to WHO [167]. This result is 
similar to findings from Burkina Faso [168] where prevalence of stunting of 8.8% in a 
similar peri-urban and urban setting were documented. However, the children from 
Burkina Faso included older children of up to 14 years and their HIV infection status 
was not determined. The stunting prevalence from our study is lower than the 
prevalence of stunting from Tanzania, another sub-Saharan African country, which 
reported stunting rates of 42.5% in children 7 to 18 years old who had a high 
prevalence of anaemia (Hb <11g/dL) of 31%, high burden of parasitic infections with 
57% suffering from Schistosoma Haematobium, however HIV status was not 
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documented [169]. Prevalence of anaemia from our study is also lower compared to 
results from studies from Asia [170-172]. Most of these studies included children 
above 5 years up to 18 years who were slightly older than the children who 
participated in our study. The exception was a study from Vietnam [162] with an 
almost identical age group (6-9 years) but slightly less number (n=292) of children 
with unknown HIV status and the study reported quite a high figure of stunting of 
33%.  The Vietnamese children demonstrated gender differences in prevalence of 
stunting and under-weight which were absent in our study. Boys were more under-
weight and stunted compared to girls. In our study, when stunting was stratified by 
HIV status, the prevalence was highest in HIV infected children (38%). This finding is 
similar to a research from Malaysia [172] in HIV infected children, but this particular 
study included children up to 18 years and had a much higher prevalence of severe 
stunting. In addition, orphaned children were more stunted in our study and this 
could be explained by the difficult socio-economic status that these children often 
endure. The prevalence of underweight (8%) found in our study was much lower 
than that reported in Vietnamese [162] and South East Asian children [171] but 
similar to findings from Malaysia [172] in HIV infected children. The overall 
prevalence of thinness (4%) was also much lower compared to an Africa study from 
Burkina Faso [168] but was similar to findings from Italy [173] a developed country. 
The 5% prevalence of overweight was comparable to findings from Burkina Faso 
[168] and South east Asia [174] which are also low income countries. It was much 
lower compared to the high income countries in children of a similar age group [173, 
175, 176] and it was also lower than findings from Malaysia [172] in HIV infected 
children on antiretroviral therapy. Some children from our study had more than one 
nutritional deficit and this has been shown to increase risk of mortality in under-five 
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children [177]. The HIV uninfected (unexposed and exposed) children above 5 years 
had better nutritional status than the HIV infected children. Prevalence of stunting 
has been shown to be high in HIV infected children on [178] and off [179] 
antiretroviral treatment. Prevalence of underweight and stunting have been reported 
to be higher among HIV infected children compared to HIV negative children [180, 
181].Though the HIV uninfected exposed group of children were slightly shorter than 
the unexposed children this was not statistically significant and their weight was also 
comparable. This finding from our study is in contrast to what has been described for 
younger children where HIV uninfected exposed children have been shown to have a 
high prevalence of under-nutrition [182, 183]compared to HIV uninfected unexposed 
children.  The head circumferences of the children 7 to 10 years old were not 
statistically different when stratified by HIV status. This could be due to survivor bias 
where many HIV infected children with advanced disease who may have had smaller 
head sizes from HIV encephalopathy died before two years of age [184]. 
 
4.1.2 Selenium Deficiency 
This is the first study that has assessed children’s selenium status in Zimbabwe. 
Overall, the prevalence of selenium deficiency (48%) was high in all the children and 
this could be reflecting the selenium soil status of the region. The prevalence of 
selenium deficiency was comparable to results from Ethiopia (62%) [163] and 
Vietnam (76%) [162]. These two studies had almost similar sample sizes, used a 
similar cut-off value to define selenium deficiency, had similar mean selenium levels 
but the HIV status of the children were not determined. The prevalence of selenium 
deficiency in our study was much higher than that obtained in HIV infected children 
on antiretroviral treatment from Malaysia (12.5%) [172] who also had a higher mean 
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selenium level (1.13 μmol/L). The Malaysian study had a smaller sample size 
compared to our study. There was no gender difference in the levels of selenium in 
our study and this was in contrast to results from Iran [185] which demonstrated that 
girls had higher serum selenium levels. In our study selenium deficiency occurred 
more frequently among children from households with a monthly income of less than 
USD$250 and from children from one site, Epworth which is in a different 
geographical location from the other two sites in Chitungwiza. The prevalence of 
selenium deficiency did not differ according to HIV status although there was a 
tendency for frequency of selenium deficiency to be higher in the 7 to 10 year old 
HIV infected children but this did not reach statistical significance. Though some 
studies have shown lower selenium levels in HIV infected individuals [186], there 
was no difference among the three groups in our study and this is similar to results 
found in Rwandan children younger than 5 years [187].It is important to note that 
selenium levels in different regions are influenced by the soil content of the element 
[188-190]. Some regions are well known for low selenium content for example areas 
in China[191] and Malawi [189].  
 
4.2 Paper 2- Anaemia and Iron Deficiency 
This is one of the few studies that have evaluated anaemia and ID in children above 
5 years born in a national PMTCT programme from an area with a high prevalence 
of HIV infection. According to WHO, the 15% prevalence of anaemia has a  mild 
public health significance as it falls between 5 and 19.9% [192]. In spite of this, 
anaemia has important effects at the individual level in school going children. Our 
study concurs with other African studies that have shown that HIV infection 
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increased the odds of anaemia in children [193-195]. However, in our study the 
maternal HIV status at birth was not related to presence of anaemia in the children 
after five years of age. 
 
 Very few children had IDA but when a higher ferritin cut off of 30 μg/L was applied 
the prevalence of IDA became of mild public health significance in this cohort. A 
small proportion of anaemia was caused by ID in these children. ID increased almost 
8 fold when the higher cut off of 30 μg/L was used. This study documented a much 
lower prevalence of anaemia, ID and IDA anaemia compared to a study done by 
Midzi et al in a rural area in Zimbabwe with a high prevalence of malaria, 
schistosomiasis and soil helminths [196]. The prevalence of anaemia and IDA 
reported by Midzi et al were 48% and 38% respectively. Our study was conducted in 
a peri-urban area around Harare, the capital city of Zimbabwe, with no malaria [197, 
198], schistosomiasis and a very low soil helminths burden [199]. Another difference 
is that Midzi et al included preschool children below five years.  Our study also differs 
from other African studies done in areas with high parasite burden which also 
reported high prevalence of anaemia (26-46%) and IDA (16-18%) [200-202]. 
Researchers from Africa and Europe have found that boys had more ID compared to 
girls [201, 203] in a similar age group to our participants, while in an Asian study ID 
was higher in girls [202]. In our study there was no gender difference in the 
occurrence of anaemia or IDA. However, our result on prevalence of anaemia 
concurs with the global estimates from WHO were Zimbabwe is estimated to have 
an anaemia prevalence of mild public health significance [192]. 
 
 
 
62 
 
Anaemia is important in school going children as it has been associated with 
reduced physical work capacity, reduced cognitive function and reduced intellectual 
performance[204]. Iron deficiency has also been shown to negatively affect physical 
growth [205], since iron is necessary for growth and metabolism[206]. Furthermore, 
ID negatively affects learning, memory, affective and social behaviour [95, 207, 208]. 
It also affects physical work performance, cognitive function, language development 
and causes poor grades at school [209-214]. ID is associated with increased gut 
uptake of other heavy metals like lead [215]. Programmes to prevent ID occurring in 
children must be in place as ID causes changes in the brain that persist for a long 
time [208]. The importance of identifying individual children including those above 5 
years with anaemia, ID and IDA should be emphasized as they all can result in 
children failing to achieve their full potential at school. This impacts on their future 
economic performance and can result in poverty. Programs should be in place to 
identify school children with anaemia, ID and IDA for intervention purposes. These 
should be continuous with the programs for infants and children under five years so 
as to have an impact in preventing the long term consequences of anaemia, ID and 
IDA. 
 
4.3 Paper 3- Omega 3 Fatty Acid Levels 
Our study happens to be the first study to determine children’s whole blood fatty acid 
levels in Zimbabwe, a low income setting with a significant burden of chronic 
malnutrition and HIV infection. We did not find any association of age and gender 
with EPA, DPA and DHA levels except that EPA median was lower in the 7 year old 
age group compared to the 8 and 9-10 year age groups. This finding differs from 
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results of a heterogeneous cohort of children 3 to 8 years old from 8 European 
countries who were well nourished where the median EPA levels in the age groups 7 
to 9 years were higher [216]. However, the median DPA and DHA levels were lower 
by almost half the quantities found in our study. This European study had a much 
larger sample size and there were subtle differences in the analytical method. In this 
European study both capillary and venous whole blood samples were used for 
determining omega 3 LCPUFA levels but we only used capillary blood samples 
collected on a dry blood spot. Another difference was the fact that 7% of the children 
who participated in our study were HIV infected, 12% chronically malnourished and 
8% underweight for age. In addition, our study also had fewer children in the 7 year 
age group and had a homogenous population of children from one peri-urban 
setting. Eicosapentaenoic acid, DPA and DHA levels documented in our study were 
lower compared to another study done in the United Kingdom (UK) in school children 
6 to 10 years old who were under performing in reading [217]. Whole blood fatty acid 
levels were determined from dry blood spot samples with minimal differences in the 
laboratory protocols. Notably, these UK 6 to 10 year old children’s omega 3 fatty acid 
levels were also higher than in the 8 European countries [216]. DPA and DHA were 
higher in boys and DPA was lower in the 7 year age group. In contrast, we found 
lower EPA in the 7 year age group. A cross-sectional study done on Danish children 
8 to 11 years old [218] who were well nourished reported higher medians than ours 
for the 3 omega fatty acid levels. This Danish study used heparinized whole blood 
samples instead of capillary DBS to determine the fatty acid levels. It is a challenge 
to compare fatty acid analysis across studies because of analytical methodological 
differences, different range of fatty acids measured, and the dietary diversity among 
the different populations. However, we have compared our study findings to studies 
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that used whole blood to measure fatty acids. Plasma has less fatty acids compared 
to erythrocyte levels but whole blood fatty acid levels though lower have been found 
to correlate to erythrocyte levels [165]. 
4.3.1 Omega 3 Fatty Acid Levels and HIV Infection 
HIV status was not associated with EPA, DPA and DHA levels in our study. In 
contrast, well-nourished Italian children one to 15 years old on highly active anti-
retroviral drugs had higher EPA and DHA compared to HIV negative controls [219]. 
In these Italian children, there were also no age or gender differences. However, this 
was a very small study with 14 HIV infected children and 30 HIV negative controls. 
An earlier study in much younger children with a median age of 2 years in Rumania 
living in an orphanage [140], malnourished HIV infected children had lower plasma 
DHA and total omega 3 LCPUFA compared to malnourished HIV negative children. 
The 35 severely malnourished Rumanian children (19 HIV infected) were also 
compared to healthy German children and the malnourished children had lower 
DPA, DHA and total omega 3 LCPUFA levels.  No studies comparing HIV exposed 
uninfected children to HIV infected or HIV unexposed uninfected children were 
identified. 
 
4.3.2 Omega 3 Fatty Acid Levels and Nutritional Status 
There was no difference in the EPA, DPA and DHA levels of the children in our study 
according to their nutritional status. This population of children was characterized by 
significant prevalence of under-nutrition, anaemia [220] and selenium deficiency 
[221]. Studies on association of omega 3 fatty acid levels and under-nutrition are 
limited especially studies that use capillary whole blood for fatty acid analysis. 
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According to a review by Smit and colleagues in 2004 essential fatty acid deficiency 
could play a role in protein energy malnutrition [135] as it is associated with low DHA 
levels. A case control study that compared children with non-organic failure to thrive 
reported higher erythrocyte EPA and DPA in well-nourished controls [222] . 
However, erythrocyte fatty acid analysis was done only in 51 cases and 9 controls. 
This unequal representation limits conclusions that can be drawn from this study. 
Nigerian severely malnourished children with kwashiorkor and marasmus defined 
using the Welcome classification [223] had low DHA levels [138]. An earlier case-
control study in Nigerian children which looked at 8 healthy children compared to 17 
severely malnourished children with either kwashiorkor or marasmus reported low 
DHA and DPA levels in the malnourished children [139].  
4.4 Study Limitations  
One of the major limitation in our study was the unequal numbers in the comparison 
groups. There was a much smaller sample size of HIV infected children (7%) 
compared to the HIV uninfected (exposed and unexposed) and the unequal numbers 
in the different age groups. We investigated serum selenium levels which reflect 
short term selenium status instead of red cell selenium levels which reflect long term 
selenium status [224]. Selenium was determined in 269 (85%) of the children. The 
children (15%) who did not have their selenium status assessed where mostly from 
Epworth (57%) and this site had more children with selenium deficiency from our 
analysis. Hence the prevalence of selenium deficiency we found is likely to be an 
underestimation of the actual value. We also did not assess the diet of the children 
which would have assisted in answering the question on why selenium and 
nutritional status were poor in this group of children. According to the 2014 
Zimbabwe Vulnerability assessment committee report [9] most households 
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consumed maize, sugar, oil, vegetables and salt almost on a daily basis. The least 
consumed food groups were meat and pulses. Meat, poultry and fish are the foods 
that contribute most of the dietary selenium [105]. Maize has been described as a 
poor source of selenium in neighbouring South Africa [225] and Malawi [226]. 
Therefore the assumption is that most of these children from a poor peri-urban area 
have reduced access to selenium rich foods. In addition, the assessment of 
nutritional status of the children was done only once; the study design does not 
address risk factors associated with the under-nutrition in the study population. 
We used haemoglobin level and serum ferritin complemented with sTfR levels to 
make a diagnosis of IDA, which is the WHO recommendation [227]. The 
recommended gold standard is bone marrow iron studies [228, 229] but this is 
invasive and difficult to justify in well children. Besides, some studies have shown 
that having unstainable bone marrow iron may not equal ID [230, 231]. C-reactive 
protein has been used by others to identify inflammation and improve reliability of 
ferritin in diagnosis of ID. Although thresholds of C-reactive protein levels that make 
ferritin unreliable are not clearly defined, thresholds of 10-30 nanograms per litre are 
used [232]. C-reactive protein levels were not measured in our study.  The 
combination of ferritin and sTfR level may allow some differentiation between ID and 
inflammation [232]. Conversely, there are studies that found sTfR level to be affected 
by inflammation [233]. In contrast, there are also studies that have found sTfR to be 
relatively independent of inflammation [234, 235]. Not using C-reactive protein or 
sTfR level to define ID resulted in underestimation of prevalence of ID in our study. 
The fact that this was a cross sectional study meant we were unable to delineate the 
causality of anaemia in these children.  
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Our study is one of the few studies to report on omega 3 fatty acid levels in 
association with HIV and nutritional status. However, because the 7 years age group 
was relatively small compared to the other two age groups, limits conclusions that 
can be drawn for this age group. This study was a cross-sectional study were 
measurement of whole blood fatty acids was done only once. Whole blood fatty 
acids reflect both the short term intake (plasma) and long term intake (erythrocyte) of 
fatty acids and percent total fatty acid levels are lower than the erythrocyte fatty 
acids as they include a wider range of fatty acids [236]. However, whole blood fatty 
acids have been found to correlate well with erythrocyte fatty acid levels [237]. The 
population of children studied was a narrow age group constituting 7 to 10 year old 
children and was made up mainly of children from very low income peri-urban 
setting. These results therefore cannot be generalized to children outside this age 
group, from rural or urban setting and from higher income households. Lastly, 
because dietary habits of the children were not studied, it remains unclear why our 
results were lower than some of the studies quoted from Europe. It is however, 
important to note that Zimbabwe is a land-locked country with reduced access to sea 
food which is a good source of omega 3 fatty acids. 
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5 CONCLUSION AND RECOMMENDATIONS 
5.1 Conclusion 
1. Chronic malnutrition and selenium deficiency were prevalent in this 7-10 year old 
cohort of children who were born in a prevention of mother-to-child transmission 
of HIV programme in a peri-urban setting from a low income country with a high 
HIV burden.  
2. The prevalence of anaemia and ID was of mild public health significance in the 7-
10 year old children. HIV infection was an important determinant for the presence 
of anaemia. IDA constituted 15% of all cases of anaemia. 
3. There was no difference by HIV status, gender and nutritional status in the 
capillary whole blood omega 3 fatty acid levels EPA, DPA and DHA in the 
children 7 to 10 years old from Zimbabwe.  
5.2 Recommendations 
1. We recommend setting up of nutrition programmes for school children above 5 
years in our setting with a high burden of HIV infection. These programmes should 
be in continuity with the under-five nutrition programmes already in existence in this 
setting. Further and larger studies that will also include children from rural and urban 
areas are recommended so as to ascertain the selenium status of this population as 
this may guide policy on the need for supplementation of selenium in Zimbabwe. 
2. HIV prevention programs for children should be strengthened to eliminate 
paediatric HIV infections as this may also reduce the cases of anaemia in school 
children in areas with high burden of HIV infection. IDA should be addressed easily 
and cheaply through iron fortification of basic food stuff such as mealie-meal and 
teaching the public to consume iron rich food.   
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3. Further studies assessing LCPUFA levels that include larger sample size, wider 
range of children from both urban and rural areas are recommended as this may 
clearly define the association of omega 3 LCPUFA with HIV status and under-
nutrition in children from low income countries. 
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6 FUTURE RESEARCH 
Our study found high prevalence of under-nutrition, selenium deficiency and 
anaemia in 7 to 10 year old children. We did not find an association between under-
nutrition and HIV status with omega 3 fatty acid levels in these children but our study 
was confined to a peri-urban population of children. I hope to assess the selenium 
and omega 3 Fatty acid status of children from rural and urban areas in Zimbabwe in 
order to have a more representative view of the selenium and omega 3 fatty acids 
status of children in my country as this will better guide policy makers in decisions on 
supplementations of these two nutrients in our setting. There is also a need for 
research assessing the impact of iron supplementation and nutrition programmes in 
school aged children from Zimbabwe.  
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ERRATA 
Page 4, line 14: “Aquaculture, and University of Stirling in Scotland” to read 
“Aquaculture, University of Stirling in Scotland” 
Page 6, line 6: “child health services.” to read  “child health services from August 
2011 to June 2012.” 
Page 7, line 6: “children and therefore nutrition programmes” to read “children, 
therefore nutrition programmes” 
Page 10, line 5: Formatted font from bold “Figure 4 Conceptual framework Integrated 
Management of Acute Malnutrition”  
Page 10, line 8: Formatted font from bold “Table 1 Zimbabwean HIV/AIDS Statistics: 
1999 and 2014” 
Page 10, line 10: Formatted font from bold “Table 3 Definition of Terms” 
Page 10, line 11: Formatted font from bold “Table 4 Classification of Prevalence of 
Anaemia in Populations Based on Haemoglobin Level [158]” 
Page 12, line 14: “have more than 90% of the burden” to read “carry more than 90% 
of the burden” 
Page 15, line 13: “PMTCT programme” to read “prevention of mother-to-child 
transmission of HIV (PMTCT) programme” 
Page 15, line 14: “nevirapine, .the government” to read “ nevirapine. The 
government” 
Page 15, line 15: “the ART programme” to read “the anti-retroviral therapy (ART) 
programme” 
Page 18, line 24: “few months (Briend2001)” to read “few months [35]” 
Page 39, line 5 and 6: “WHO used to interpret the public health significance of the 
prevalence as shown in Table 2.”  to read “WHO was used to interpret the public 
health significance of the prevalence as shown in Table 4.” 
Page 45, line 16: “Table 1 shows the socio-demographic features of the children.” to 
read “Table 5 shows the socio-demographic features of the children.” 
Page 46, line 6: “shown in Table 2.” to read “shown in Table 6.” 
Page 46, line 10: “children as shown in Table 3.”  to read “children as shown in Table 
7.” 
Page 48, line 5: “ in Table 5.” to read “in Table 8.” 
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Page 51, line 15: ‘in Table 5.” to read “ in Table 9.” 
Page 52, line 2: “applied (Table 6)” to read “ applied (Table 10)” 
Page 55, line 4: “shown in Table 7.” to read “shown in Table 11.” 
Page 67, line 8: “factors associated” to read “risk factors associated” 
Page 69, line 5: “HIV transmission programme” to read “HIV programme”  
Page 69, line 14: “1 We” to read “1. We” 
Page 69, line 20: “2 HIV” to read “2. HIV” 
Page 70, line 1: “3 Further” to read “3. Further” 
Paper 2 word document replaced with PDF from the Central African Journal of 
Medicine. 
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APPENDICES 
Appendix 1 ENGLISH CONSENT FORM 
BURDEN OF MALNUTRITION IN 7-10 YEAR OLD CHILDREN  BORN IN A  
MOTHER-TO-CHILD TRANSMISSION OF HIV INFECTION PREVENTION 
PROGRAMME, ZIMBABWE 
Principal Investigator: Patience Kuona [MBChB, MMED Paediatrics (UZ)] 
Co-Investigator(s): Marshall Munjoma 
Phone number(s): 0772396029 / 0734612649 
What you should know about this research study: 
x We give you this consent so that you may read about the purpose, 
risks, and benefits of this research study. 
x Routine care is based upon the best known treatment and is provided 
with the main goal of helping the individual patient.  The main goal of 
research studies is to gain knowledge that may help future patients. 
x We cannot promise that this research will benefit your child.  Just like 
regular care, this research can have side effects that can be serious or 
minor. 
x You have the right to refuse to allow your child to take part, or agree 
for your child to take part now and change your mind later. 
x Whatever you decide, it will not affect your child’s regular care. 
x Please review this consent form carefully.  Ask any questions before 
you make a decision. 
x Your choice to allow your child to participate is voluntary. 
x If you have questions concerning this study , you can contact: Dr 
Patience Kuona at 0772396029 
PURPOSE 
Malnutrition and iron deficiency are major problems in our children. These 
problems affect children in the short and long term with a big effect on the 
involved child and the society. The levels of omega 3 fatty acids and selenium 
in our children are unknown. You are being asked to participate in a research 
study to find out how common malnutrition and iron deficiency are in a cohort of 
children who were born in a national PMTCT program in the Better Health for 
African Mothers and Children study. This research is also going to find out the 
levels of selenium and omega 3 fatty acids in the children who are now of 
school going age. The results of this study could assist us in knowing how 
children born in a national PMTCT program grow after birth and improve their 
care. Your child was selected because they were born in the BHAMAC study 
cohort. The research team is made up of doctors, nurses and scientists. The 
research is funded by The Lettern Foundation. 
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Procedures 
If you allow your child to take part in this research, a few questions will be 
asked about your child and their health. A doctor will examine your child. We 
will collect a few drops of blood from your child by a needle prick on the thumb 
and blot it on a filter paper. We will also draw 5ml of blood for measuring 
selenium levels. This will only be done once. We also request your permission 
to store unused blood from your child. Omega 3 test and selenium are not 
available in the country currently. We also request your permission to take 
some of the blood outside the country so these tests can be done. If your child 
is wasted, you will be asked to give them a therapeutic food known as plumpy 
nut. We will then follow up your child for at most 4 months to see if their 
nutritional status recovers. We will measure their weekly weight gain. 
 
Risk and discomforts 
The blood testing may cause discomfort or a small bruise as with any other 
blood test. Plumpy nut is peanut based and may cause allergy to susceptible 
individuals. 
 
Benefits and/ or compensation 
The study result will help us understand the growth pattern and nutritional state 
of the children born in a national PMTCT program. It will define if there is 
significant iron deficiency in school going children and levels of omega 3 fatty 
acid levels and selenium. This could influence policy on supplementation of 
these nutrients. This will assist us in improving care to children born in PMTCT 
programs. By participating in this research you will have the advantage of 
knowing your child’s nutritional status. Illness that occur during the study period 
will be treated free of charge. Taking part in this study will not cost you. All tests 
will be done free of charge. We will not pay you to take part in the study but we 
will refund transport cost for the study visits. 
 
Confidentiality 
Information about you will be stored using a study number in safe paper and 
computer files. No-one will be able to access the information about you except 
the research team. No-one will be able to identify your child from the 
information we will collect. Dr Patience Kuona will be responsible for keeping 
your personal information confidential.  
 
Voluntary Participation and withdrawal 
Participation in this research is voluntary. If you decide not to participate, your 
decision will not affect your future relationship with this clinic, and University of 
Oslo. If you decide to participate you are free to withdraw your consent and 
assent at any time and discontinue participation without penalty. 
 
In the event of injury, contact Dr Kuona at 0772396029 
 
Before you sign this form, please ask any questions on any aspect of this study that 
is unclear to you.  You may take as much time as necessary to think it over. 
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AUTHORIZATION 
YOU ARE MAKING A DECISION WHETHER OR NOT TO ALLOW YOUR CHILD 
TO PARTICIPATE IN THIS STUDY.  YOUR SIGNATURE INDICATES THAT YOU 
HAVE READ AND UNDERSTOOD THE INFORMATION PROVIDED ABOVE, 
HAVE HAD ALL YOUR QUESTIONS ANSWERED, AND HAVE DECIDED TO 
ALLOW YOUR CHILD TO PARTICIPATE. 
The date you sign this document to enrol your child in this study, that is, today’s 
date, MUST fall between the dates indicated on the approval stamp affixed to each 
page.  These dates indicate that this form is valid when you enrol your child in the 
study but do not reflect how long your child may participate in the study.  Each page 
of this Informed Consent Form is stamped to indicate the form’s validity as approved 
by the MRCZ. 
    
Name of Parent (please print)  Date 
    AM 
Signature of Parent or legally authorized representative Time PM 
  
Relationship to the Subject 
 _______________________________   ________________________________________
Signature of Witness Signature of Research Staff 
(Optional)  
 YOU WILL BE GIVEN A COPY OF THIS CONSENT FORM TO KEEP. 
If you have any questions concerning this study or consent form beyond those 
answered by the investigator, including questions about the research, your rights as 
a research subject or research-related injuries; or if you feel that you have been 
treated unfairly and would like to talk to someone other than a member of the 
research team, please feel free to contact the Medical Research Council of 
Zimbabwe on telephone 791792 or 791193. 
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Appendix 2 ASSENT FORM 
BURDEN OF MALNUTRITION IN 7-10 YEAR OLD CHILDREN BORN IN A 
MOTHER-TO-CHILD TRANSMISSION OF HIV INFECTION PREVENTION 
PROGRAMME, ZIMBABWE 
ASSENT FORM- MRCZ/B/222 
My name is Patience Kuona. I am doing a research study to describe the growth 
pattern and nutritional status of children who were born in a national program to 
prevent mother to child transmission of HIV infection. I am going to ask you and your 
caregiver some questions, examine you and take some blood from you. You may be 
given a nutritional supplement called plumpynut depending on your nutritional status. 
You are allowed to refuse to take part and we will continue treating you as usual 
without prejudicing you. This research is going to assist in describing the growth, 
nutritional status, levels of omega 3 fatty acid levels and selenium in children born in 
national PMTCT programs.  
I have discussed this clinical research study with the child using language which is 
understandable and appropriate.  I believe I have fully informed this participant of the 
nature of the study and its possible risks and benefits.  I believe the participant 
understood this explanation and assented to participate in this study 
Ini ndinonzi Patience Kuona. Ndirikutarisa vana vakazvarwa muchirongwa 
chekudzivirira chirwere cheHIV ndakanangana nekutarisisa kukura kwavo. Izvi 
zvichabatsira kuti tizive kuti ropa ravo rine maomega 3 fatty acids, selenium 
uye iron yakakwana here. Zvichabatsira kuchengetwa kwevana ava pakukura 
kwavo.Ini ndichakubvunza mibvunzo nemubereki wako, ndokutarisa uye 
nekukutora ropa richanotariswa kulaboratory.  Wakasununguka kuramba 
kutariswa kunyangwe wanga wambobvuma hako isu tinoramba tichikurapa 
semazuva ose.  
________________________________________  
 ______________________ 
Name (Zita rako)      Date (Zuva) 
_______________________________________ 
 ______________________ 
Signature of Research Staff     Date 
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Appendix 3 SPECIMEN STORAGE INFORMED CONSENT FORM 
SPECIMEN STORAGE INFORMED CONSENT FORM 
Chitungwiza (St Mary’s and Seke North Clinics) and Epworth  
 
BURDEN OF MALNUTRITION IN 7-10 YEAR OLD CHILDREN BORN IN A MOTHER-TO-
CHILD TRANSMISSION OF HIV INFECTION PREVENTION PROGRAMME, ZIMBABWE 
Protocol Version 2 08 July 2011 
MRCZ/B/222 
SPECIMEN STORAGE AND SHIPMENT 
Consent Version  
(English) 
 
PRINCIPAL INVESTIGATOR: Patience Kuona 
PHONE: 0772396029 
INTRODUCTION: 
You have decided to take part in the investigational research study named above, sponsored 
by the Lettern Foundation.  While in this study, blood will be collected from your child. You 
are kindly being asked to agree to the storage of these samples for use during the 
study and after the study have ended. We are also asking to ship these samples to 
another laboratory outside Zimbabwe. This consent form gives you information about 
the collection, storage, and use of these samples.  These samples may be useful for 
future research. The study staff will talk to you about this information.  Please ask if you 
have any questions.  You will be asked to sign or make your mark on this form to indicate 
whether you agree to have your child’s samples stored and tested.  You will be offered a 
copy of this form to keep. 
YOUR PARTICIPATION IS VOLUNTARY: 
Allowing your samples to be stored is completely voluntary.  You may decide not 
to have any samples stored other than what is needed to complete this study and still be in 
this research study or any future study. Even if you decide now that your samples can be 
stored for future research, you may change your mind at any time.  If this happens, you must 
tell the study staff that you have changed your mind.  If you decide not to have your samples 
stored or used for future research, they will be destroyed at the end of the study.   
PURPOSE: 
The specific research to be done on the samples from your child include measuring your 
haemoglobin, selenium, omega 3 fatty acid, serum ferritin and serum transferrin receptor 
levels. Your child’s samples will only be used for these tests only.  No other kinds of tests 
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will be done by anyone on your child’s stored specimens without first explaining the test to 
you and obtaining your permission. 
The study researchers do not plan to contact you or your child’s regular doctor with any results 
from tests done on the stored samples.  This is because research tests are often done 
using experimental procedures, so the results may not help for making decisions on 
managing your health.  In the case that a specific test result gives important information about 
your health, the researchers will tell the study staff and the study staff will try to contact you.  
If you wish to be contacted with this type of test result, you must give the study staff any 
change to your contact information.  If your child has a regular doctor and you want the study 
staff to tell this doctor the test results, you must give the study staff the doctor’s contact 
information. Your child’s samples will not be sold or used directly to produce commercial 
products. Research studies using your samples will be reviewed by the Norwegian Ethics 
Board and a special committee at the Medical Research Council of Zimbabwe. 
PROCEDURES: 
We will collect a few drops of blood from your child by a needle prick on the thumb and blot it 
on a filter paper. We will also draw 5ml of blood for measuring selenium levels. This will only 
be done once. Each time your child’s blood is drawn, up to 2mL (which is about half a 
teaspoon) of the sample may be stored. Your blood will be stored safely and securely in a 
storage facility at the University of Zimbabwe.  Only the people who work at the facility and 
approved researchers will have access to your child’s samples.  The people who 
work at the facility will not have any information that identifies your child.  The 
approved researchers may be given information about your child such as their age 
and sex, but they will not be given the child’s name or any other information that identifies 
your child. Your child’s samples may be shipped to approved researchers who work outside 
of Zimbabwe. There is no time limit on how long your samples will be stored. 
RISKS and/or DISCOMFORTS: 
There are few risks related to storing your samples.  When tests are done on the stored 
samples there is a rare but possible risk to your privacy.  It is possible that if others 
found out information about your child that is learned from tests (such as information about 
your genes) it could cause you problems with your family (having a family member learn about 
a disease that may be passed on in families or learning who the true parent of a child 
is). 
POTENTIAL BENEFITS: 
There are no direct benefits to you from having your samples stored.  You and others could 
benefit in the future from research done on your blood. 
CONFIDENTIALITY: 
To keep your information private, your child’s samples will be labelled with a code that can 
only be traced back to your study clinic.  Your child’s name, where they live, and 
other personal information will be protected by the study clinic.  When researchers are 
given your child’s stored samples, they will not be given your personal information.  
The results of future tests will not be included in your child’s health records.  Every 
effort will be made to keep your child’s personal information confidential, but we cannot 
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guarantee absolute confidentiality.  Your child’s personal information may be disclosed if 
required by law. 
Efforts will be made to keep your child’s study records and test results confidential to the 
extent permitted by law.  However, we cannot guarantee absolute confidentiality.  
Your child will be identified by a code, and personal information from their records will not be 
released without your written permission.  Any publication of this study will not use 
your child’s name or identify them personally.   However, your child’s records may be 
reviewed by the Norwegian Ethics Board, the Medical Research Council of Zimbabwe and 
the study staff. 
In addition to the efforts made by the study staff to keep your child’s personal information 
confidential, an Oath of Confidentiality was signed by all our staff working in this study. This 
Oath requires study staff not to tell people who are not connected with this study, information 
about your child or other study participants or any other information related to the study. 
PROBLEMS OR QUESTIONS: 
For questions about the storage of your 
samples, contact: 
Patience Kuona 0772396029 
 
For questions about your rights as a research 
subject, contact: 
The National Coordinator 
Medical Research Council of Zimbabwe 
National Institute of Health Research  
Cnr Mazoe Street/ Josiah Tongogara 
Avenue 
Harare 
Ph: +263 4 791792, 791193 
Cell: +263 912 433 166  
CONSENT FOR SPECIMEN STORAGE AND SHIPMENT 
Please carefully read the statements below (or have them read to you) and think about your 
choice.  No matter what you decide it will not affect whether you can be in the research 
study, or your routine health care. 
________ I agree to have samples of my child’s blood shipped outside the country, stored and 
used for future testing related to nutrition of children. 
________ I agree to have samples of my child’s blood shipped outside the country but do not 
want it to be stored and used for future testing related to nutrition of children. 
________ I do not agree to have samples of my child’s blood shipped outside the country, 
stored and used for future testing related to nutrition in children. 
                 ____________________________________ 
Participant Caregiver/ Parent Name (print)   Participant Caregiver Signature or Mark and 
Date 
   ____________________________________ 
Study Staff Conducting    Study Staff Signature and Date 
Consent Discussion (print) 
   ____________________________________ 
Witness Name (print)    Witness Signature and Date 
(As appropriate) 
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Appendix 4 DATA COLLECTION TOOL 
Nutritional Assessment Questionnaire 
1. Study ID No:……………………. 
2. Date of interview:…………………..  
3. Site:………………… 
4. Date of Birth:………………… 
5. Age (years):………….. 
6. Gender: 1. Female 2. Male   
7. Birth rank:  
8. HIV status: 1. Negative 2. Positive    
9. At Birth:  Height (cm)   
10. At birth: Weight (kg)   
11. At Birth:  OFC (cm)    
12. 4-6 weeks: Height       
13. 4-6 weeks: Weight   
14. 4-6 weeks: OFC   
15. 3-4 months: Height   
16. 3-4 months: Weight   
17. 3-4 months: OFC   
18. 9 months: Height   
19. 9 months: Weight   
20. 9months: OFC   
21. Current: Height   
22. Current: Weight   
23. Current: OFC    
24. Feeding method at birth:  1. Breast milk    2.Formula   3.Mixed  
25. Exclusive breast feeding period (months) or age introduced other liquids and solids: 
26. Age stopped breast feeding (months): 
27. Primary care giver: 1. mother 2. Maid 3. Other 
28. Mother: 1.Alive  2.Died 
29. If alive how old is she (years): 
30. Level of education attained: 1.primary  2. Secondary 3. diploma / degree 
31. Occupation: ………………. 1. Formal 2. informal 
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32. Marital status: 1.Single 2.Married 3.Divorced 4.Widowed 
33. Father: 1.Alive  2.Died 
34. If alive does he live in the same household with child?  1.Yes  2.No 
35. Household monthly income (in US dollars):………………  
36. Total number adults and children in household:………….. 
37. Number children < 10 years in household: 
38. Diagnosis: 1.No malnutrition 2.stunted 3.wasted 
 4.overweight 5.obese 
39. Blood for selenium collected:  1.Yes 2.No 
40. Haemoglobin  level:………….. 
41. Filter paper whole blood spot  for ferritin, serum transferrin receptor  and omega 3 
prepared. 1. Yes 2. No   
42. Therapeutic feed indicated:  1.Yes 2.No 
43. Amount  of  RUTF required per week: 
44. Weekly weight gain (grams):  
week 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
weight                 
Gain/ 
loss 
                
 
Follow up appointment card 
 Review date:      Time:   Clinic: 
 
